WO2005121115A1 - PROCESS FOR THE MANUFACTURE OF CHROMAN DERIVATIVES, ESPECIALLY α-TOCOPHEROL AND ALKANOATES THEREOF - Google Patents

PROCESS FOR THE MANUFACTURE OF CHROMAN DERIVATIVES, ESPECIALLY α-TOCOPHEROL AND ALKANOATES THEREOF Download PDF

Info

Publication number
WO2005121115A1
WO2005121115A1 PCT/EP2004/013771 EP2004013771W WO2005121115A1 WO 2005121115 A1 WO2005121115 A1 WO 2005121115A1 EP 2004013771 W EP2004013771 W EP 2004013771W WO 2005121115 A1 WO2005121115 A1 WO 2005121115A1
Authority
WO
WIPO (PCT)
Prior art keywords
tocopherol
formula
catalyst
reaction
acid
Prior art date
Application number
PCT/EP2004/013771
Other languages
French (fr)
Inventor
Werner Bonrath
Yann Foricher
Thomas Netscher
Angela Wildermann
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Priority to EP04803493.8A priority Critical patent/EP1778661B1/en
Priority to JP2007526211A priority patent/JP4999690B2/en
Priority to CN2004800433093A priority patent/CN1968943B/en
Priority to KR1020067025975A priority patent/KR101140519B1/en
Publication of WO2005121115A1 publication Critical patent/WO2005121115A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/723,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Definitions

  • the present invention relates to a novel process for the manufacture of chroman deriva- tives, especially for the manufacture of ⁇ -tocopherol (TCP) and alkanoates (TCPA) thereof such as ⁇ -tocopheryl acetate (TCP Ac), whereby at least one step of the process is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure.
  • TCP ⁇ -tocopherol
  • TCPA alkanoates
  • TCP Ac ⁇ -tocopheryl acetate
  • the absolute pressure of the reaction is at least 1.1 bar, more preferably it is from about 1.1 bar to about 20.0 bar, even more preferably it is from about 1.1 bar to about 6.0 bar.
  • TCP and its alkanoates either a mixture of 2,3,5-trimethylhydroquinone (TMHQ) or 2,3,6-trimethylhydroquinone-l-alkanoate (TMHQA) and a compound selected from the group consisting of phytol (PH), isophytol (IP) and (iso)phytol derivatives, or the "open ring" compound 2-phytyl-3,5,6-trimethyl- hydroquinone (PTMHQ), a 3-phytyl-2,5,6-trimethylhydroquinone-l-alkanoate (PTMHQA) and/or an isomer thereof are used.
  • TMHQ 2,3,5-trimethylhydroquinone
  • THQA 2,3,6-trimethylhydroquinone-l-alkanoate
  • PH phytol
  • IP isophytol
  • PTMHQA 3-phytyl-2,5,6-trimethylhydroquinone-l-alkanoate
  • PTMHQA 3-phytyl-2
  • (all-r ⁇ c)-(X-tocopherol (or as it has mostly been denoted in the prior art, "d,l- ⁇ -tocopherol”) is a mixture of four diastereomeric pairs of enantiomers of 2,5,7,8-tetra- methyl-2-(4',8',12'-trimethyl-tridecyl)-6-chromanol ( ⁇ -tocopherol), which is the biologically most active and industrially most important member of the vitamin E group.
  • OMocopherol by the reaction of TMHQ with PH or phytyl bromide in the presence of anhydrous ZnCl 2 is e.g. described in US 2,411,967.
  • DE 196 54 038 Al TMHQ is reacted with PH or IP to (X-tocopherol and its acetate in the presence of ZnCl 2 and a proton donor, whereby ⁇ n the process of US 3,708,505 a combined acid condensation agent comprising a Lewis acid such as ZnCl 2 and at least one strong acid such as p-toluene sulfonic acid and sodium bisulfate is used as the catalyst.
  • PH or a PH derivative are reacted in the presence of a mineral acid, a Lewis acid, an acidic ion exchange resin or a triflate, nitrate or sulfate of Sc, Y or a lanthanide element as the catalyst.
  • Sc(IH) triflate as cata- lyst for the condensation of TMHQ with IP is also described in Bull. Chem. Soc. Jpn. 1995, 68, 3569-3571.
  • TCP can be converted into its acetate, succinate and further known application forms by standard methods, e. g. as described in Ullmann's Encyclopedia of Industrial Chemis- try, Vol. A27, 5 th edition, pages 484 to 485, VCH Verlagsgesellschaft mbH, D-69451 Weinheim, 1996.
  • esters In contrast to TCP which is labile against oxidative conditions, the esters (TCPA) are more stable and more convenient to handle.
  • the object of the present invention is to provide a process for the manufacture of chroman derivatives such as tocols and tocopherols and of their alkanoates, especially of (X-toco- pherol and its alkanoates, with high selectivities and yields.
  • this object is achieved by the use of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar. It has been surprisingly found that pressure has a positive effect on the condensation reaction of phenols such as TMHQ or TMHQA with compounds such as IP, PH or a derivative thereof and on the ring closure reaction of PTMHQ or PTMHQA and/or isomers thereof to produce ⁇ -tocopherol as well as on the acylation of tocols and tocopherols.
  • R 1 is hydrogen, acetyl, propionyl, pivaloyl, HO 2 C-CH 2 -CH 2 -CO, nicotinoyl or benzoyl,
  • R 2 is hydroxy, acetyloxy, benzoyloxy or halogen,' and n is an integer from 0 to 3, and whereby the reaction is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar.
  • This process is referred to as PROCESS 1 hereinafter.
  • substituent R 1 preferably it is hydrogen or acetyl, more preferably it is hydrogen.
  • R is hydroxy, acetyloxy, benzoyloxy, chlorine 9 or bromine, more preferably R is hydroxy, acetyloxy or chlorine, most preferably R is hydroxy.
  • n preferably n is 3.
  • PROCESS 1 of the present invention the production of (all-rac)-2-alkenyl-3,5,6- trimethylhydroquinone, e.g. (all-r ⁇ c)-PTMHQ, or (all-rac)-3-alkenyl-2,5,6-trimethyl- hydroquinone 1-alkanoate, e.g. (all-r ⁇ c)-PTMHQA, especially (all-r ⁇ c)-3-phytyl-2,5,6-tri- methylhydroquinone-1-acetate (PTMHQAc), is preferred, the invention is not limited to the production of that particular isomeric form and other isomeric forms can be obtained by using e.g.
  • (R,R)-PTMHQ or (i?,i?)-PTMHQA will be obtained e.g. when using (R,R)- phytol, (i?,i?,/?)-isophytol, (,S,i?,i?)-isophytol or (i?S,i?,i?)-isophytol or an appropriate (iso)phytol derivative.
  • PROCESS 1 is also applicable for the alkenylation of phenols comprising 0 to 4 methyl groups, a total of 1 to 3 hydroxy groups and at least one unsubstituted position, whereby the unsubstituted position is ortho to a hydroxy group.
  • a further object of the present invention is a process for the alkenylation of phe- nols comprising 0 to 4 methyl groups, a total of 1 to 3 hydroxy groups and at least one unsubstituted position, whereby the unsubstituted position is ortho to a hydroxy group, with a compound of the formula m and/or IV in an organic solvent
  • R 2 and n having the same meanings and preferences as above, and whereby the reaction is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar.
  • This process is referred to as PROCESS 1 A hereinafter.
  • R 3 being hydrogen, acetyl, propionyl, pivaloyl, HO 2 C-CH 2 -CH -CO, nicotinoyl or benzoyl
  • X 1 , X 2 and X 3 being independently from each other hydrogen or methyl, with the proviso that R 3 is only acetyl, propionyl, pivaloyl, HO 2 C-CH 2 -CH 2 -CO, nicotinoyl or benzoyl, if X 1 , X 2 and X 3 are all methyl; i.e.
  • hydroquinone, 2-methylhydroquinone, 2,3-di- methylhydroquinone, 2,5-dimethylhydroquinone, 2,6-dimethylhydroquinone, 2,3,5- trimethylhydroquinone and 2,3,6-trimethylhydroquinone-l-alkanoates Preferred from this group are 2,3,5-trimethylhydroquinone and 2,3 ,6-trimethylhydroquinone-l -alkanoates, more preferred are 2,3,5-trimethylhydroquinone and 2,3,6-trimethylhydroquinone-l- acetate, the most preferred is 2,3,5-trimethylhydroquinone.
  • R , R and n having the same meanings and preferences as above, and
  • steps a) and b) is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar.
  • This process is referred to in the following as PROCESS 2.
  • R 1 , R 2 and n having the same meanings and preferences as above, whereby the reaction is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar.
  • This process is referred to in the following as PROCESS 3.
  • phytol, isophytol or a derivative thereof as the starting material in the appropriate isomeric form e.g. (RS,R,R)- ⁇ CP/(RS,R,R)- ⁇ C?A will be obtained when using (R,R)-VTMHQ, (R,R)- PTMHQA, (i?,i?)-phytol, (i?,i?,i?)-iso ⁇ hytol, (S,R,R)-iso ⁇ p ytol or (ftSJ?,i?)-isophytol or an appropriate (iso)phytol derivative.
  • (RS,R,R)- ⁇ CP/(RS,R,R)- ⁇ C?A will be obtained when using (R,R)-VTMHQ, (R,R)- PTMHQA, (i?,i?)-phytol, (i?,i?,i?)-iso ⁇ hytol, (S,R,R)-iso ⁇ p ytol or (ftSJ?
  • the present invention is concerned with a process for the manufacture of compounds of the formula Vila by a) (STEP a) optionally reacting a compound of the formula Ha
  • steps a) and b) is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar.
  • a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar.
  • step a of PROCESS 2 A can also proceed to the final products, the compounds of the formula Vila, so that the compounds of the formula la are not isolated.
  • a further aspect of the present invention is the manufacture of a compound of the formula Vila
  • reaction is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar.
  • a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar.
  • reaction is carried out in the presence of a Lewis acid as the catalyst.
  • reaction is car- ried out at reduced pressure, preferably at an absolute pressure of below 0.9 bar, or under pressure, preferably at an absolute pressure of at least 1.1 bar (in the following referred to as PROCESS 5).
  • n it is an integer from 0 to 3.
  • R it is selected from the group consisting of acetyl, propionyl, pivaloyl, HO 2 C-CH 2 -CH 2 -CO, nicotinoyl or benzoyl; preferably R is HO 2 C-CH 2 -CH 2 - CO or acetyl, more preferably R is acetyl.
  • an acylating agent characterized in that the reaction is carried out in the presence of a Lewis acid as the catalyst at reduced pressure, preferably at an absolute pressure of below 0.9 bar, or under pressure, preferably at an absolute pressure of at least 1.1 bar (in the following referred to as PROCESS 5A).
  • R it is selected from the group consisting of acetyl, propionyl, pivaloyl, HO 2 C-CH 2 -CH 2 -CO, nicotinoyl or benzoyl; preferably R is HO 2 C-CH 2 -CH 2 - CO or acetyl, more preferably R is acetyl.
  • R 1 being acetyl, propionyl, pivaloyl, HO 2 C-CH 2 -CH 2 -CO, nicotinoyl or benzoyl, and n being an integer from 0 to 3,
  • (X) can also be manufactured by reacting a compound of the formula X with R 1 being hydrogen and n having the same meaning as above with an appropriate acylating agent in the presence of a Lewis acid as the catalyst at reduced pressure, preferably at an absolute pressure of below 0.9 bar, or under pressure, preferably at an absolute pressure of at least 1.1 bar.
  • a Lewis acid as the catalyst at reduced pressure, preferably at an absolute pressure of below 0.9 bar, or under pressure, preferably at an absolute pressure of at least 1.1 bar.
  • (all-rac)- ⁇ -tocopherol can be acetylated at the reaction temperature the mixture already has.
  • indium(IE) salts are used as the catalysts, the acetylation even proceeds at room temperature in a short reaction time (up to 10 minutes).
  • acetylation (all-r ⁇ c)- ⁇ -tocopheryl acetate was isolated in excellent yield [>99.5% based on (all-rac)- ⁇ -tocopherolj.
  • Lewis acids and mixtures of Lewis acids with Bronsted acids known to the person skilled in the art as catalysts for the condensation reaction of TMHQ or TMHQA with IP, PH or derivatives thereof can be used.
  • Suitable catalysts are e.g. bortrifluoride (BF 3 ), a mixture of boric acid (especially orthoboric acid) and oxalic acid, triflates and het- ero wolfram acids.
  • InCl 3 , In(OTf) 3 and Sc(OTf) 3 are more preferred, whereby InCl 3 is the most preferred one.
  • the indium and scandium salts InCl 3 , In(OTf) 3 and Sc(OTf) 3 are known compounds which are commercially available, InCl 3 e.g. from Fluka (No. 57 100), In(OTf) 3 and Sc(OTf) 3 e.g. from Aldrich (No.442 151 and 418 218). They can be used in solid form, anhydrous or hydrated (of which rnCl 3 '4 H 2 O is an example), as well as in solution or in suspension.
  • the catalyst is preferably dissolved or suspended in water.
  • the concentration of such an aqueous solution is not critical * Furthermore, all the Lewis acids cited above tolerate acetic anhydride and other acylating agents as well as protic solvents such as acetic acid, methanol, ethanol and water. After the termination of the reaction the Lewis acids used as the catalysts can be recycled.
  • Suitable mixtures of Lewis acids with Bronsted acids are the following systems: zinc(E) compounds/hydrochloric acid, zinc(E) compounds (preferably ZnCl 2 )/gaseous HCl and Fe(E) chloride/gaseous HCl.
  • the Fe(E) chloride can be prepared in situ by the reaction of Fe with HCl, which therefore presents an equivalent system to the system Fe(E) chloride/gaseous HCl.
  • Suitable zinc(E) compounds are zinc(E) salts such as ZnCl 2 , ZnBr 2 as well as all zinc(E) compounds which form ZnCl under the reaction conditions, e.g. ZnO.
  • the reaction is carried out in the presence of an amine such as disclosed in the last paragraph on page 4 and the first paragraph on page 5 of EP 0 100 471 Al, which is hereby incorporated by reference, or in the presence of an ammonium salt.
  • the reaction is preferably carried out by using the compound of the formula El or TV such as IP or PH having been pretreated with an amine or NH 3 as described in DE-OS 26 06 830.
  • the starting material TMHQ Ac maybe obtained e.g. by selective hydrolysis of 2,3,5- trimethylhydroquinone diacetate as described in EP-A 1 239 045.
  • 2,3,5-Trimethylhydro- quinone diacetate can be prepared e.g. by the acid catalyzed rearrangement of ketoiso- phorone in the presence of acetic anhydride or another acetylation agent as described in EP-A 0 850 910, EP-A 0 916 642, EP-A 0 952 137 or EP-A 1 028 103.
  • the most preferred starting material selected from the (iso)phytyl compounds is IP. Of course any other appropriate isomeric form of the (iso)phyt ⁇ l derivatives can also be used.
  • PROCESS 1 STEP a of PROCESS 2.
  • STEP a of PROCESS 2a STEP a of PROCESS 2a
  • TMHQ/TMHQA is reacted with a compound of the formula IE and/or IV with n being 3 in both formulas
  • PTMHQ/PTMHQA and their isomers represented by the formulae Va and Via are intermediates for the production of ⁇ -tocopherol or its alkanoates (final products).
  • step a and b of PROCESS 2 the reaction proceeds to the final product (steps a and b of PROCESS 2) or is slowly enough so that these inter- mediates can be isolated (only step a of PROCESS 2 is performed). The same applies for the steps a and b of PROCESS 2a.
  • TMHQ is reacted with PH and/or IP, more preferably with IP.
  • reaction is carried out under an inert gas atmosphere, preferably gaseous nitrogen or argon.
  • the reaction is preferably carried out at an absolute pressure of at least 1.1 bar, more pref- erably at an absolute pressure of from about 1.1 to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar, even more, more preferably at an absolute pressure of from about 1.7 to about 5.1 bar, most preferably at an absolute pressure of from about 2.0 to about 3.6 bar.
  • the reaction temperature depends on the applied pressure and solvent because the reaction is carried out under reflux. Therefore, the reaction temperature is conveniently from about , 90°C to about 170°C, preferably from about 90°C to about 160°C, more preferably from ; about 112°C to about 160°C and most preferably from about 125 to about 150°C.
  • Suitable organic solvents are aprotic non-polar organic solvents such as aliphatic hydro- carbons, halogenated aliphatic hydrocarbons, aromatic hydrocarbons, halogenated aromatic hydrocarbons and mixtures thereof.
  • Preferred examples of aliphatic hydrocarbons are linear, branched or cyclic C 5 - to C 15 - alkanes. Particularly preferred are linear, branched or cyclic C 6 - to C 10 -alkanes, especially preferred are hexane, heptane, octane and cyclohexane or mixtures thereof.
  • halogenated aliphatic hydrocarbons are mono- or polyhalogenated linear, branched or cyclic Ci- to C 15 -alkanes.
  • Especially prefened examples are mono- or polychlorinated or -brominated linear, branched or cyclic C ⁇ - to C 15 -alkanes. More pre- ferred are mono- or polychlorinated linear, branched or cyclic - to C 15 -alkanes.
  • Most prefened are 1,1,1-trichloroethane, 1,2-dichloroethane, methylene chloride and methylene bromide.
  • aromatic hydrocarbons are benzene, toluene, o-, m- and p-xylene, 1,2,3-trimethylbenzene, mesitylene, pseudocumene, naphthalene and mixtures thereof, particularly prefened is toluene.
  • halogenated aromatic hydrocarbons are mono-or polyhalogenated benzene. Especially prefened are chlorobenzene, 1,2-dichlorobenzene, 1,3-dichloro- benzene and 1,4-dichlorobenzene.
  • the most prefened solvent for carrying out the reaction with the Zn(E) catalyst system is hexane. If no amine is present, the most prefened solvent for carrying out the reaction with the Zn(E) catalyst system is heptane.
  • the molar ratio of the compound of the formula E or Ea (most prefened: TMHQ or TMHQA(c)) to a compound of the formula IE or IV, whichever is employed, in the reaction mixture conveniently varies from about 0.95 : 1 to about 1 : 1.1, preferably from about 1 : 1.01 to about 1 : 1.05.
  • the amount of the aprotic non-polar organic solvent used is conveniently from about 0.1 ml to about 6.0 ml, preferably from about 0.15 ml to about 3.0 ml, based on 1 mmol of the compound of the formula IE or IV, whichever is employed.
  • the relative amount of catalyst, based on compound IE or IV, whichever is employed, is dependent on the catalyst system used and the reactants. Conveniently the relative amount of the catalyst based on compound IE or IV, whichever is employed, is at least 0.01 mol%. Generally the relative amount of catalyst varies from about 0.01 to about 30 mol%. The optimal relative amount of the catalyst is different from catalyst to catalyst and also depends on the reactants: If InCl 3 is used as the catalyst, it may be preferably present e.g.
  • a relative amount of from about 0.1 mol% to about 2.5 mol% especially preferable in a relative amount of from about 0.1 mol% to about 2.0 mol%, more preferably in a relative amount of from about 0.1 to about 1.0 mol%, even more preferably in a relative amount of from about 0.1 to about 0.5 mol%, based on compound IE or IV, whichever is employed.
  • Sc(OTf) 3 is used as the catalyst, it may be preferably present in a relative amount of from about 0.05 mol% to about 2.0 mol%, preferably in a relative amount of from about 0.075 to about 1.5 mol%, more preferably in a relative amount of from about 0.1 to about 1.0 mol%, based on compound IE or IV, whichever is employed.
  • Fe and/or FeCl 2 in combination with HCl is used as the catalyst, it may be present in an amount as described e.g. in DE - OS 21 60 103 (page 5, end of second paragraph and ⁇ • • claim 9) and in US 3,789,086 (column 3, lines 27 - 60).
  • Zn(E) and/or ZnCl 2 is used as the catalyst, it may be present in an amount as described e.g. in.the examples 1 to 12 of US 2,411,967, in US 3,708,505 (page 1, right column, lines 26 - 44), in DE - OS 196 54 038 (page 2, lines 55 - 63; page 3, lines 4 - 6; page 3, line 60 to page 4, line 19; page 4, line 29 - 38), in EP-A 0 100471 (page 7, lines 19 - 24), in DE - OS 26 06 830 (page 4, last two lines to page 5, first two paragraphs), in US 4, 191, 692 (second column, lines 49 - 62).
  • the expression "amount of catalyst” is to be understood as referring to the weight of pure Lewis acid or pure Bronsted acid present, even though the catalyst may be impure, in the form of an adduct with a solvent and/or a solution/suspension.
  • the relative amount of the Bronsted acid depends also on the Lewis acid used and can be chosen accordingly.
  • the reaction can be carried out batchwise or continuously, and in general operationally in a very simple manner, for example (i) by adding the compound of the formula IE or IV - as such or dissolved in the solvent, preferably as such - portionwise or continuously to a mixture of the Lewis acid, the compound of the formula Ea/E (prefened: TMHQ or TMHQA; most prefened: TMHQ or TMHQ Ac) and the solvent. If a catalyst system consisting of a Lewis acid and a Bronsted acid is employed, the Bronsted acid is added continuously or batchwise, preferably continuously, to the mixture of the Lewis acid, the compound of the formula Ea/E (most prefened: TMHQ or TMHQA(c)) and the solvent.
  • the compound of the formula IE or IV is added continuously to the compound of the formula Ea/E (most prefened: TMHQ or TMHQA(c)) within about 15 to about 180 minutes, preferably within about 30 to about 150 minutes, more preferably within about 45 to about 130 minutes.
  • the Lewis acid is preferably added at once, i.e. in its full amount, to the mixture of the compound of the formula Ea/E (most prefened: TMHQ or TMHQA(c)) and the solvent.
  • reaction mixture After completion of the addition of the compound of the formula IE or IV (in the non-polar solvent) the reaction mixture is suitably heated further at the reaction temperature for about 10 minutes to about 360 minutes, preferably for about 30 minutes to about 240 minutes.
  • the working-up can be effected by procedures conventionally used in organic chemistry.
  • a compound of the formula E or Ea with R 1 and R 3 , respectively, being hydrogen such as PTMHQ or an isomer thereof as a reactant in the process of this invention will result in the preparation of a tocol or a tocopherol such as ⁇ - tocopherol while, when using a compound of the formula E with R 1 being acetyl, propionyl, pivaloyl, HO 2 C-CH 2 -CH 2 -CO, nicotinoyl or benzoyl and n being 3 the respective to- cyl alkanoate or tocopheryl alkanoate such as ⁇ -tocopheryl alkanoate will be obtained.
  • PTMHQ or PTMHQ A and optionally one or more isomers thereof which are obtained as minor by-products in the manufacture of PTMHQ or PTMHQ A, prepared to any method known to the person skilled in the art can be used as starting material.
  • PTMHQ or PTMHQA and optionally one or more isomers thereof are produced according to STEP a, it is sufficient to simply prolong the reaction time of STEP a to realize STEP b, i.e. to prolong the reaction time for about 30 minutes to about 240 minutes, to increase the amount of catalyst and/or to increase the reaction temperature.
  • PROCESSES 3 and 3a This reaction can be carried out using the same catalysts under substantially the same reaction conditions as described above for step a) of PROCESS 2 and 2a. Depending on the kind of catalyst, the amount of catalyst and the reaction temperature the reaction stops at the intermediates of the formula Ia/I or proceeds to the end products of the formula VE/VEa.
  • PROCESS 4 This reaction can be carried out using the same catalysts under substantially the same reaction conditions as described above for step a) of PROCESS 2 and 2a. The reaction proceeds to the final product of the formula X independent from the nature of the catalyst, the amount of catalyst and the reaction temperature.
  • a compound of the formula VEc such as e.g. ⁇ -tocopherol or ⁇ -tocopherol, or any other tocol as described in DE-OS 21 60 103 on page 5 in the third and forth paragraph may be converted into its alkanoate (a compound of the formula VEIa), e.g. its acetate, by treatment with an acylating agent in the presence of a Lewis acid as the catalyst at reduced pressure, preferably at an absolute pressure of below 0.9 bar, or under pressure, preferably at an absolute pressure of at least 1.1 bar.
  • the absolute reaction pressure varies from about 0.02 bar to about 0.9 bar (even more preferably from about 0.1 bar to about 0.9 bar, most preferably from about 0.2 bar to about 0.9 bar) and from about 1.1 bar to about 10.0 bar (even more preferably from about 1.1 bar to about 6.0 bar, even more, more preferably from about 1.1 bar to about 5.0 bar, most preferably from about 1.1 bar to about 3.0 bar).
  • the invention is also directed to a process for the manufacture of tocyl alkanoates in the presence of a Lewis acid as the catalyst at reduced pressure, preferably at an absolute pressure of below 0.9 bar, or under pressure, preferably at an absolute pressure of at least 1.1 bar.
  • the acylation in accordance with that aspect of the invention can be carried out using acy- lating agents conventionally used in the acylation of tocopherols such as anhydrides or halides.
  • Examples of these are anhydrides or halides of alkanoic acids such as acetic acid, propi- onic acid, pivalic acid, succinic acid, nicotinic acid and benzoic acid.
  • acetic anhydride or acid chloride, especially acetic anhydride are/is used.
  • the molar ratio of the compound of the formula VEc to the acylating agent in the reaction mixture conveniently varies from about 1 : 1 to about 1 : 5, preferably from about 1 : 1 to about 1 : 3, more preferably from about 1 : 1.1 to about 1 : 2.
  • Suitable Lewis acids are the ones named above.
  • the amount of the Lewis acid used as the catalyst is based on the lesser molar amount of reactant, i.e. the compound of the formula VEc or the acylating agent, and can be in the range of from about 0.006 mol% to about 2.0 mol%, preferably from about 0.0075 mol% to about 1.5 mol%, more preferably from about 0.01 mol% to about 1.0 mol%, in the batchwise mode of operation.
  • the amount of catalyst will be ad- justed to the size of the reactor and the flow of the reactants. It will be appreciated that the determination of the appropriate figures based on the figures for batchwise operation is within normal skill.
  • the Lewis acid is added at once, i.e. in its full amount.
  • the catalyst is added as an aqueous, solution or suspension.
  • the temperature of the acylation is dependent on the catalyst system used and the temperature the reactants (resulting from former process steps) already have.
  • the acylation reaction can be generally carried out at temperatures from about 20 to about 200°C, preferably from about 60 to about 180°C, more preferably from about 80 to about 160°C.
  • the acylation reaction is preferably carried out at temperatures below 120°C, more preferably from about 15 to about 120°C, most preferably at room temperature, i.e. from about 15 to about 40°C.
  • the reaction can be carried out essentially in the absence of an additional organic solvent, which is prefened.
  • Essentially in the absence of an additional organic solvent in the context of the present invention means that essentially no organic solvent is present during the reaction and that no organic solvent is deliberately added. It might, however, be possible that traces of organic solvent are present in the starting materials or the catalyst as impurities.
  • the reaction is carried out in substance; i.e. no other compound except the compound of the formula VEc, the acylating agent and the catalyst is intendedly used for the reaction, so that at the beginning of the reaction the amount of any substance except for the starting material, the compound of the formula VEc and the acylating agent, and except for the catalyst in the reaction mixture is ⁇ 5 weight%, preferably ⁇ 3 weight%, more preferably ⁇ 0.5 weight%, and that no further compound is added during the reaction
  • the reaction is conveniently carried out under an inert gas atmosphere, preferably gaseous nitrogen or argon.
  • acylation when using chiral tocols and tocopherols, e.g. (enantiomeric pure) (R,R,R)- ⁇ -tocopherol, the acylation proceeds substantially without epimerization in the presence of indium(IE) salts as the catalysts and at a temperature below 120°C, e.g. from about 20°C to about 120°C.
  • indium(IE) salts as the catalysts and at a temperature below 120°C, e.g. from about 20°C to about 120°C.
  • the appropriate acetates are manufactured, especially with indium(ET) salts (preferences see above) as the catalysts and at a temperature below 120°C, preferably at room temperature, i.e. a temperature between 15 and 40°C.
  • ⁇ -tocopherol or its alkanoates obtained by one of the processes of the present invention can further be formulated by any method known to the person skilled in the art, e.g.
  • Jeffsol EC50® is a solvent mixture available from Huntsman Corp., PO Box 15730 Aus- tin, Texas, USA/Antwe ⁇ 2030, Belgium, which consists of ethylene carbonate and propylene carbonate in the volume ratio 1 : 1.
  • Examples 1-3 InCl 3 as the catalyst 12.88 mmol of TMHQ and 8.58 mmol of IP were reacted in the solvent or solvent system given in Table 1 in the presence of InCl 3 as the catalyst (amounts of the catalyst given in Table 1) and at atmospheric pressure. The reaction time was 2 hours. For further details and the results see Table 1.
  • Examples 4 and 5 In(QTfh as the catalyst 12.88 mmol of TMHQ and 8.58 mmol of IP were reacted in a mixture of 20 ml of heptane and 20 ml of Jeffsol EC 50® in the presence of increasing amounts (see Table 1) of In(OTf) 3 as the catalyst and at atmospheric pressure. For further details about the reaction conditions and the results see Table 1.
  • Example 8 In(OTfh as the catalyst TMHQ (38.63 mmol) and IP (25.75 mmol, 97%, added during 1 hour) were reacted in a : molar ratio of 1.5 : 1 in the presence of 1.0 mol% of fr ⁇ (OTf) 3 as the catalyst (amount based on IP) at 22°C and at atmospheric pressure.
  • TMHQ 38.63 mmol
  • IP 25.75 mmol, 97%, added during 1 hour
  • Example 9 In(OTfh as the catalyst TMHQ (24.691 g, 161.1 mmol) and'ff (38.833 ml, 107.4 mmol, 97%, added during 1 hour) were reacted in a molar ratio of 1.5 : 1 in the presence of 1.0 mol% of In(OTf) 3 as the catalyst (amount based on IP) at 22°C and at atmospheric pressure.
  • TMHQ 2, 4°H
  • 1.1 mmol% of In(OTf) 3 as the catalyst (amount based on IP) at 22°C and at atmospheric pressure.
  • Table 2 After separation of the heptane phase and washing of the heptane phase with Jeffsol EC50® (250 ml) the resulting suspension in heptane was filtered under vacuum. The pasty nearly colorless solid was analysed by quantitative GC.
  • Examples 10-14 200 mmol of TMHQ were reacted with 200 mmol of IP (examples 10 and .13) and 203 mmol of IP (examples 11, 12 and 14), respectively, in the presence of increasing amounts of fr ⁇ (OTf) 3 (example 10) or rnCl 3 (examples 11-14) as the catalyst in 100 ml of an organic solvent.
  • Examples 10 and 14 were carried out under pressure, whereby examples 11-13 were carried out at atmospheric pressure. For the reaction temperature, the pressure, the reaction time and the type of solvent see Table 3.
  • the amount of solvent was 100 ml in all cases.
  • the amount of TMHQ was 200 mmol in all cases.
  • a molar excess of IP of 1.5 mol% based on the amount of TMHQ was used.
  • the yield of PTMHQ is based on IP.
  • Example 25 Preparation of (all-rac -TCP with InCl 3 as the catalyst and under pressure 200 mmol of TMHQ and 203 mmol of ff were reacted in 100 ml of toluene at 137°C. The ff was added during 120 minutes. The reaction mixture was then further reacted for an- other 60 minutes. The yield - based on IP - is given in Table 6. See also Table 7.
  • Example 26 Preparation of (all-rac -TCP with InCl 3 as the catalyst and under pressure 200 mmol of TMHQ and 203 mmol of ff were reacted in 100 ml of toluene at 137°C. The ff was added during 120 minutes. The reaction mixture was then reacted for further 566 minutes. The yield - based on IP - is given in Table 6.
  • Example 27 Preparation of (all-rac)-TCP with InCl 3 as the catalyst and under pressure 200 mmol of TMHQ and 203 mmol of ff were reacted in 100 ml of heptane at 147°C. The ff was added during 120 minutes. The reaction mixture was then further reacted for an- other 120 minutes. The yield - based on IP - is given in Table 6.
  • Example 28 Preparation of (all-racVTCP in cyclohexane at an absolute pressure of 4.0 bar 200 mmol of TMHQ and 203 mmol of ff were reacted in 100 ml of cyclohexane at 135°C and under an absolute pressure of 4.0 bar in the presence of 0.5 mol% of L ⁇ Cl 3 - based on ff. The ff was added during 120 minutes. Afterwards the mixture was reacted for further 380 minutes. The yield of (all-rac)-TCP given in Table 7 is based on IP.
  • Example 32 Preparation of (all-rac)-TCP without azeotropic removal of water
  • 200 mmol of TMHQ and 200 mmol of ff were reacted in 100 ml of toluene in the presence of 0.1 mol% of Sc(OTf) 3 - based on ff.
  • the ff was added during 60 minutes at an absolute pressure of 3.6 bar and at a temperature of 140°C. Afterwards the mixture was reacted for further 60 minutes at the same temperature and pressure.
  • the yield and selectivity of (all-rac)-TCP given in Table 9 is based on ff.
  • Examples 34 and 35 Preparation of fall-rac -TCP with azeotropic removal of water Examples 30 and 31 were repeated, but instead of 0.1 mol% of Sc(OTf) 3 1.0 mol% of Sc(OTf) 3 were used. The yield and selectivity of (all-r ⁇ c)-TCP, based on IP, is given in Table 9. Example 36 Example 35 was repeated but the reaction was carried out at a higher temperature and at a higher pressure. For details and the results see Table 9 and 12.
  • Example 37 Preparation of fall-rac -TCP without azeotropic removal of water Example 32 was repeated, but instead of 0,1 mol% of Sc(OTf) 3 1.0 mol% of Sc(OTf) 3 were used.
  • Example 38 was repeated with the same amounts of TMHQ, ff and Fe.
  • the amount of HCl and the time for the addition of ff were, however, different.
  • the pressure, under which the reaction was carried out was also slightly different in the examples 39-41. For further details and the results see Table 10 and 13 (examples 41 and 42 only).
  • Example 46 was repeated but the reaction was carried out under an absolute pressure of 2.1 bar instead of 1.0 bar. Further details and the results are shown in Table 10.
  • Example 48 Preparation of (all-r c)-TCP in heptane in the absence of an amine at atmospheric pressure 322, mmol of TMHQ and 320 mmol of IP were reacted, in 163.3g of heptane under reflux in the presence of ZnCl 2 and gaseous HCl as the catalyst (amounts see Table 11). The reaction was carried out at 1.0 bar. Further details and the results are given in Table 11.
  • Example 48 was repeated, but the reaction carried out under an absolute pressure of 2.1 bar and not at 1.0 bar. Further details and the results are given in Table 11.
  • Example 50 Preparation of (all-r ⁇ c)-TCP in hexane in the presence of an amine under pressure
  • Example 51 Preparation of (all-r ⁇ cVTCP in hexane in the presence of an amine under pressure
  • Example 50 was repeated, but instead of 403 mmol of ff 404 mmol of ff were added and instead of 5.3 g of gaseous HCl 49.9 g of gaseous HCl were used.
  • Table 11 For further details- and the results see Table 11.
  • Example 52 Preparation of (all-mcVTCP in hexane in the presence of an amine at atmospheric pressure
  • Example 51 was repeated with the amounts of TMHQ, ff, ZnCl 2 , tridecyl amine and gaseous HCl given in Table 11. The reaction, however, was not carried out at 2.2 bar, but at 1.0 bar. The results are presented in Table ' 11.
  • Example 51 was repeated with the amounts of TMHQ, ff, ZnCl 2 , tridecyl amine and gaseous HCl given in Table 11. The reaction, however, was not carried out in hexane, but in heptane. The results are presented in Table 11 and 13.
  • Table 11 Comparison between experiments at atmospheric pressure (1.0 bar) and under pressure (2.1 - 2.2 bar) in heptane under reflux (examples 48, 49 and 53) or hexane under reflux (examples 50-52) with ZnCl 2 /HCl( g) as the catalyst, ff was added during one hour in all cases. All yields and selectivities are based on ff. The conversion of ff was 100% in all cases.
  • fr Cl 3 shows a higher selectivity for the formation of TCP than fr ⁇ (OTf) 3 and Sc(OTf) 3 .
  • Table 13 Detailed results and comparison of selectivity for a mixture of Bronsted with Lewis acids as the catalyst

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to novel processes for the manufacture of chroman deriva­tives such as α-tocopherol (TCP) and alkanoates thereof, especially α-tocopheryl acetate (TCPA), whereby at least one step of the processes is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, pref­erably at an absolute pressure of at least 1.1 bar. As starting materials for the manufacture of TCP and its alkanoates either a mixture of 2,3,5-trimethylhydroquinone (TMHQ) or 2,3,6-trimethylhydroquinone-l-alkanoate (TMHQA) and a compound selected from the group consisting of phytol (PH), isophytol (IP) and (iso)phytol derivatives or 2-phytyl-3,5,6-trimethyl-hydroquinone (PTMHQ)/3-­ phytyl-2,5,6-trimethylhydroquinone-1-alkanoate (PTMHQA) and/or an isomer thereof are used. Suitable Lewis acids are indium(III) salts and scandium(III) salts. Suitable acid mixtures are iron/iron(II) chloride/hydrogen chloride and zinc(II) chloride/hydrogen chloride.

Description

Process for the manufacture of chroman derivatives, especially α-tocopherol and alkanoates thereof
The present invention relates to a novel process for the manufacture of chroman deriva- tives, especially for the manufacture of α-tocopherol (TCP) and alkanoates (TCPA) thereof such as α-tocopheryl acetate (TCP Ac), whereby at least one step of the process is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure. Preferably the absolute pressure of the reaction is at least 1.1 bar, more preferably it is from about 1.1 bar to about 20.0 bar, even more preferably it is from about 1.1 bar to about 6.0 bar.
As starting materials for the manufacture of TCP and its alkanoates either a mixture of 2,3,5-trimethylhydroquinone (TMHQ) or 2,3,6-trimethylhydroquinone-l-alkanoate (TMHQA) and a compound selected from the group consisting of phytol (PH), isophytol (IP) and (iso)phytol derivatives, or the "open ring" compound 2-phytyl-3,5,6-trimethyl- hydroquinone (PTMHQ), a 3-phytyl-2,5,6-trimethylhydroquinone-l-alkanoate (PTMHQA) and/or an isomer thereof are used.
As is known, (all-røc)-(X-tocopherol (or as it has mostly been denoted in the prior art, "d,l- α-tocopherol") is a mixture of four diastereomeric pairs of enantiomers of 2,5,7,8-tetra- methyl-2-(4',8',12'-trimethyl-tridecyl)-6-chromanol (α-tocopherol), which is the biologically most active and industrially most important member of the vitamin E group. Many processes for the manufacture of "d,l-o.-tocopheror (referred to as such in the literature reviewed hereinafter) and its acetate by the reaction of TMHQ/2,3,6-trimethyl- hydroquinone-1 -acetate (TMHQAc) with IP or PH in the presence of a catalyst or catalyst system and in a solvent or solvent system are described in the following selected literature.
The manufacture of OMocopherol by the reaction of TMHQ with PH or phytyl bromide in the presence of anhydrous ZnCl2 is e.g. described in US 2,411,967. According to DE 196 54 038 Al TMHQ is reacted with PH or IP to (X-tocopherol and its acetate in the presence of ZnCl2 and a proton donor, wherebyϊn the process of US 3,708,505 a combined acid condensation agent comprising a Lewis acid such as ZnCl2 and at least one strong acid such as p-toluene sulfonic acid and sodium bisulfate is used as the catalyst.
In EP-A 0 100 471 the reaction of TMHQ with IP or PH in the presence of a Lewis acid, e.g. ZnCl2, BF3 or A1C13, a strong acid, e.g. HC1, and an amine salt as the catalyst system is described. In the processes of DE-OS 26 06830 and US 4,191,692 the IP or PH is pre- treated with ammonia or an amine before the reaction with TMHQ in the presence of ZnCl2 and an acid is effected.
In the processes of DE-OS 21 60 103 as well as US 3,789,086 compounds of the following formula
Figure imgf000003_0001
wherein X is hydrogen, alkanoyl or aroyl, and R1, R2 and R3 are individually hydrogen or methyl, are reacted with compounds of the following formulae
Figure imgf000003_0002
wherein Y is -CH2-CH(CH3)- or -CH=C(CH3)- and A is halogen, hydroxy, etherified hydroxy or esterified hydroxy in the presence of HC1 and Fe and/or FeCl2 as the catalyst to obtain e.g. α-tocopherol. According to EP-A 0 694 541 TMHQ and IP, PH or a PH derivative are reacted in the presence of a mineral acid, a Lewis acid, an acidic ion exchange resin or a triflate, nitrate or sulfate of Sc, Y or a lanthanide element as the catalyst. The use of Sc(IH) triflate as cata- lyst for the condensation of TMHQ with IP is also described in Bull. Chem. Soc. Jpn. 1995, 68, 3569-3571.
TCP can be converted into its acetate, succinate and further known application forms by standard methods, e. g. as described in Ullmann's Encyclopedia of Industrial Chemis- try, Vol. A27, 5th edition, pages 484 to 485, VCH Verlagsgesellschaft mbH, D-69451 Weinheim, 1996. In contrast to TCP which is labile against oxidative conditions, the esters (TCPA) are more stable and more convenient to handle.
The object of the present invention is to provide a process for the manufacture of chroman derivatives such as tocols and tocopherols and of their alkanoates, especially of (X-toco- pherol and its alkanoates, with high selectivities and yields.
According to the present invention this object is achieved by the use of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar. It has been surprisingly found that pressure has a positive effect on the condensation reaction of phenols such as TMHQ or TMHQA with compounds such as IP, PH or a derivative thereof and on the ring closure reaction of PTMHQ or PTMHQA and/or isomers thereof to produce α-tocopherol as well as on the acylation of tocols and tocopherols.
Therefore, in one aspect, the present invention is concerned with a process for the manufacture of 2-alkenyl-3,5,6-trimethylhydroquinone (formula I with n = 0 to 3; R1 = hydro- gen) and 3-alkenyl-2,5,6-trimethylhydroquinone 1-alkanoate (formula I with n = 0 to 3; R1 = acetyl, propionyl, pivaloyl, HO C-CH2-CH2-CO, nicotinoyl or benzoyl), most preferably a process for the manufacture of 2-phytyl-3,5,6-trimethylhydroquinone (formula I with R1 = hydrogen and n = 3) and 3-phytyl-2,5,6-trimethylhydroquinone-l-alkanoates (formula I with R1 = acetyl, propionyl, pivaloyl,- HO2C-CH2-CH2-CO, nicotinoyl or benzoyl and n = 3),
Figure imgf000005_0001
by reacting 2,3,5-trimethylhydroquinone (formula II with R1 = hydrogen) and 2,3,6- trimethylhydroquinone- 1-alkanoate (formula II with R1 = acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl), respectively,
Figure imgf000005_0002
with a compound of the formula III and/or IV in an organic solvent
Figure imgf000005_0003
whereby R1 is hydrogen, acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl,
R2 is hydroxy, acetyloxy, benzoyloxy or halogen,' and n is an integer from 0 to 3, and whereby the reaction is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar. This process is referred to as PROCESS 1 hereinafter.
Concerning the substituent R1: preferably it is hydrogen or acetyl, more preferably it is hydrogen.
9 9
Concerning the substituent R : preferably R is hydroxy, acetyloxy, benzoyloxy, chlorine 9 or bromine, more preferably R is hydroxy, acetyloxy or chlorine, most preferably R is hydroxy.
Concerning the integer n: preferably n is 3.
While in PROCESS 1 of the present invention the production of (all-rac)-2-alkenyl-3,5,6- trimethylhydroquinone, e.g. (all-rαc)-PTMHQ, or (all-rac)-3-alkenyl-2,5,6-trimethyl- hydroquinone 1-alkanoate, e.g. (all-rαc)-PTMHQA, especially (all-rαc)-3-phytyl-2,5,6-tri- methylhydroquinone-1-acetate (PTMHQAc), is preferred, the invention is not limited to the production of that particular isomeric form and other isomeric forms can be obtained by using e.g. phytol (formula IV with R2 = OH and n = 3), isophytol (formula m with R2 = OH and n = 3) or a derivative thereof as the starting material in the appropriate isomeric form. Thus, (R,R)-PTMHQ or (i?,i?)-PTMHQA will be obtained e.g. when using (R,R)- phytol, (i?,i?,/?)-isophytol, (,S,i?,i?)-isophytol or (i?S,i?,i?)-isophytol or an appropriate (iso)phytol derivative.
PROCESS 1 is also applicable for the alkenylation of phenols comprising 0 to 4 methyl groups, a total of 1 to 3 hydroxy groups and at least one unsubstituted position, whereby the unsubstituted position is ortho to a hydroxy group.
Therefore, a further object of the present invention is a process for the alkenylation of phe- nols comprising 0 to 4 methyl groups, a total of 1 to 3 hydroxy groups and at least one unsubstituted position, whereby the unsubstituted position is ortho to a hydroxy group, with a compound of the formula m and/or IV in an organic solvent
Figure imgf000007_0001
with R2 and n having the same meanings and preferences as above, and whereby the reaction is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar. This process is referred to as PROCESS 1 A hereinafter.
Concerning the phenols used in PROCESS 1 A as the starting material: Especially suitable phenols have the following formula Ha
Figure imgf000007_0002
with R3 being hydrogen, acetyl, propionyl, pivaloyl, HO2C-CH2-CH -CO, nicotinoyl or benzoyl, and X1, X2 and X3 being independently from each other hydrogen or methyl, with the proviso that R3 is only acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl, if X1, X2 and X3 are all methyl; i.e. hydroquinone, 2-methylhydroquinone, 2,3-di- methylhydroquinone, 2,5-dimethylhydroquinone, 2,6-dimethylhydroquinone, 2,3,5- trimethylhydroquinone and 2,3,6-trimethylhydroquinone-l-alkanoates. Preferred from this group are 2,3,5-trimethylhydroquinone and 2,3 ,6-trimethylhydroquinone-l -alkanoates, more preferred are 2,3,5-trimethylhydroquinone and 2,3,6-trimethylhydroquinone-l- acetate, the most preferred is 2,3,5-trimethylhydroquinone. In another aspect, the present invention is concerned with a process for the manufacture of compounds of the formula VII, preferably α-tocopherol (formula VII with R1 = hydrogen and n = 3) and its alkanoates (formula VII with R1 = acetyl, propionyl, pivaloyl, HO2- CH2-CH2-CO, nicotinoyl or benzoyl and n = 3)
Figure imgf000008_0001
by a) (STEP a) optionally reacting 2,3,5-trimethylhydroquinone (formula II with R1 = hy- drogen) and 2,3,6-trimethylhydroquinone 1-alkanoate (formula II with R1 = acetyl, propionyl, pivaloyl, HO C-CH -CH2-CO, nicotinoyl or benzoyl), respectively,
Figure imgf000008_0002
with a compound of the formula in and/or IV in an organic solvent
Figure imgf000008_0003
with R , R and n having the same meanings and preferences as above, and
b) (STEP b) submitting in an organic solvent a 2-alkenyl-3,5,6-trimethylhydroquinone (formula I with R1 = hydrogen), preferably 2-phytyl-3,5,6-trimethylhydroquinone (formula I with R1 = hydrogen and n = 3), a 3-alkenyl-2,5,6-trimethylhydroquinone 1-alkanoate (formula- 1 with R1 = acetyl, propionyl, pivaloyl, HO2C-CH -CH2-CO, nicotinoyl or benzoyl), preferably 3-phytyl-2,5,6-trimethylhydroquinone 1-alkanoate (formula I with R1 = acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl and n = 3) and optionally one or more double bond isomers thereof, all obtainable by step a),
Figure imgf000009_0001
to ring closure to form chroman derivatives VII, preferably α-tocopherol (formula VII with R1 = hydrogen and n = 3) or its alkanoate (formula VII with R1 = acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl and n = 3),
whereby at least one of the steps a) and b) is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar. This process is referred to in the following as PROCESS 2.
Depending on the activity of the catalyst and the reaction conditions, the reaction of com- pounds of the formula II with compounds of the formula m and/or IV proceeds to the final product of the formula VII, preferably α-tocopherol and its alkanoate, so that the compounds of the formula I such as PTMHQ (formula I with R1 = hydrogen and n = 3) and PTMHQA (formula I with R1 = acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl and n = 3) are not isolated.
Therefore, a further aspect of the present invention is the manufacture of chroman derivatives VII such as α-tocopherol (formula VII with R1 = hydrogen and n = 3) and its alkanoates (formula VII with R1 = acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl and n = 3)
Figure imgf000010_0001
(VII)
by reacting 2,3,5-trimethylhydroquinone (formula II with R1 = hydrogen) and 2,3,6- trimethylhydroquinone 1-alkanoate (formula II with R1 = acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl), respectively,
Figure imgf000010_0002
00
with a compound of the formula IH and/or a IV in an organic solvent
Figure imgf000010_0003
(E/Z) (IV)
with R1, R2 and n having the same meanings and preferences as above, whereby the reaction is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar. This process is referred to in the following as PROCESS 3.
As starting material in PROCESS 3 also a compound of the formula IX instead of a compound of the formula III and/or IV
Figure imgf000011_0001
may be used, so that compounds of the formula X
Figure imgf000011_0002
(X) 1 9 are obtained. R , R and n have the same meanings and preferences as above. To this process it will be referred to in the following as PROCESS 4.
While in the PROCESSES 2 and 3 of the present invention the production of (all-r c)- chroman derivatives such as (all-røc)-TCP (formula VII with R1 = hydrogen and n = 3) and (all-røe)-TCPA (formula VII with R1 = acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl and n = 3), especially (all-rαc)-TCPAc (formula VII with R = acetyl and n = 3), is preferred, the invention is not limited to the production of that particular isomeric form and other isomeric forms can be obtained by using e.g. phytol, isophytol or a derivative thereof as the starting material in the appropriate isomeric form. Thus, e.g. (RS,R,R)-τCP/(RS,R,R)-τC?A will be obtained when using (R,R)-VTMHQ, (R,R)- PTMHQA, (i?,i?)-phytol, (i?,i?,i?)-isoρhytol, (S,R,R)-isoτp ytol or (ftSJ?,i?)-isophytol or an appropriate (iso)phytol derivative.
In an especially preferred embodiment of the invention TMHQ is reacted with PH (formula T with R2 = OH and n = 3) and/or IP (formula m with R2 = OH and n = 3), preferably with IP, to α-tocopherol (formula VH with R1 = hydrogen and n = 3), whereby as intermediates compounds of the formula V (see below) and VI (see below) such as 2-phytyl-3,5,6- trimethylhydroquinone (formula I with R1 = hydrogen and n = 3; as main component), 2- (3,7,ll,15-tetramethyl-hexadec-3-enyl)-3,5,6-trimethylhydroquinone (formula Va with R1 = hydrogen) and 2-[3-(4,8,12-trimethyl-tridecyl)-but-3-enyl]-3,5,6-trimethylhydroquinone (formula Via with R1 = hydrogen) are formed.
Figure imgf000012_0001
Figure imgf000012_0002
PROCESSES 2 and 3 can also be carried out by using phenols of the formula Ha, whereby, beside α-tocopherol and its alkanoates, e.g. other tocols (formula Vila with n - 3) and to- copherols (formula Vila with n = 3) can be obtained.
Figure imgf000012_0003
Therefore, in another aspect, the present invention is concerned with a process for the manufacture of compounds of the formula Vila by a) (STEP a) optionally reacting a compound of the formula Ha
Figure imgf000012_0004
with a compoimd of the formula HI and/or IV in an organic solvent
Figure imgf000013_0001
with R2, R3, n, X1, X2 and X3 having the same meanings and preferences as above, and b) (STEP b) submitting in an organic solvent a compound of the formula la and optionally one or more double bond isomers thereof, all obtainable by step a), to ring closure to form a compound of the formula Vila,
Figure imgf000013_0002
whereby at least one of the steps a) and b) is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar. To this process it will be referred to in the following as PROCESS 2A.
Depending on the activity of the catalyst and the reaction conditions, step a of PROCESS 2 A can also proceed to the final products, the compounds of the formula Vila, so that the compounds of the formula la are not isolated.
Therefore, a further aspect of the present invention is the manufacture of a compound of the formula Vila
Figure imgf000014_0001
by reacting a compound of the formula Ha
Figure imgf000014_0002
with a compound of the formula IE and/or IV in an organic solvent
Figure imgf000014_0003
with R >2 , R , n, v Xl , X v2 and X having the same meanings and preferences as above,
whereby the reaction is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar, more preferably at an absolute pressure of from about 1.1 bar to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar. To this process it will be referred to in the following as PROCESS 3A. In still another aspect the invention relates to a process for the manufacture of compounds of the formula VHId (if n = 3: tocyl alkanoates and tocopheryl alkanoates), especially α- tocopheryl alkanoates (formula VHId with n = 3, X1== X2 = X3 = methyl),
Figure imgf000015_0001
(Vllld)
by reacting a compound of the formula Vlld (if n = 3: a tocol or tocopherol), especially α- tocopherol (formula Vlld with n = 3, X1 = X2 = X3 = methyl), obtained according to the process of the present invention,
Figure imgf000015_0002
(Vlld)
with an acylating agent. In a preferred embodiment the reaction is carried out in the presence of a Lewis acid as the catalyst. In another preferred embodiment the reaction is car- ried out at reduced pressure, preferably at an absolute pressure of below 0.9 bar, or under pressure, preferably at an absolute pressure of at least 1.1 bar (in the following referred to as PROCESS 5).
Concerning the symbol n: it is an integer from 0 to 3.
Concerning the symbols X , X and X : they have the same meanings as given above.
Concerning the substituent R: it is selected from the group consisting of acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl; preferably R is HO2C-CH2-CH2- CO or acetyl, more preferably R is acetyl. In a preferred aspect the invention relates to a process for the manufacture of compounds of the formula Villa, preferably of compounds of the formula VEIa with n = 3 (tocyl alka- noates and tocopheryl alkanoates), more preferably of α-tocopheryl alkanoates (formula Vm with n = 3),
Figure imgf000016_0001
(VIII) (Villa)
by reacting a compound of the formula VEc, preferably a compound of the formula VEc with n = 3 (a tocol or tocopherol), more preferably α-tocopherol (formula V b with n = 3),
Figure imgf000016_0002
with an acylating agent characterized in that the reaction is carried out in the presence of a Lewis acid as the catalyst at reduced pressure, preferably at an absolute pressure of below 0.9 bar, or under pressure, preferably at an absolute pressure of at least 1.1 bar (in the following referred to as PROCESS 5A).
Concerning the symbols n. X1, X2 and X3: they have the same meanings as given above.
Concerning the substituent R: it is selected from the group consisting of acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl; preferably R is HO2C-CH2-CH2- CO or acetyl, more preferably R is acetyl. hi the same way as compounds of the formula VIE and VEIa are manufactured compounds of the formula X with R1 being acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl, and n being an integer from 0 to 3,
Figure imgf000017_0001
(X) can also be manufactured by reacting a compound of the formula X with R1 being hydrogen and n having the same meaning as above with an appropriate acylating agent in the presence of a Lewis acid as the catalyst at reduced pressure, preferably at an absolute pressure of below 0.9 bar, or under pressure, preferably at an absolute pressure of at least 1.1 bar. To this process, which is also an object of the present invention, it will be referred to as PROCESS 5B in the following.
While in a prefened embodiment of PROCESS 5 A of the present invention chroman alka- noates of the formula VEIa such as (all-rαc)-TCPA (formula V T with n = 3; see above), especially (all-røc)-TCPAc (formula VIE with n = 3 and R = acetyl) is produced, the invention is not limited to the production of that particular isomeric form and other isomeric forms can be obtained by e.g. using TCP (formula VEb with n = 3) as the starting material in the appropriate isomeric form. Thus, e.g. (R,R,R)-TCP A/TCP Ac will be obtained when using (R,R,R)-TCP as starting material, since no epimerization occurs at reaction temperatures below 120°C. The same applies for the other compounds of the formula VEc used as starting materials such as e.g. tocols and tocopherols, if n = 3.
In a preferred embodiment the (all-røc)-α-tocopherol (formula VEb with n = 3) obtained by PROCESS 2 or 3 is acetylated after removal of the solvent without further purification with acetic anhydride and with total conversion, if PROCESS 2 or 3 is carried out in the presence of a Lewis acid as the catalyst. No additional catalyst needs to be used as the catalyst (Lewis acid) is still present from the reaction before. Furthermore, it is a special advantage that the reaction mixture of the manufacture of e.g. (all-rac)-α-tocopherol can vantage that the reaction mixture of the manufacture of e.g. (all-rac)-α-tocopherol can be acetylated at the reaction temperature the mixture already has. When indium(IE) salts are used as the catalysts, the acetylation even proceeds at room temperature in a short reaction time (up to 10 minutes). After acetylation (all-røc)-α-tocopheryl acetate was isolated in excellent yield [>99.5% based on (all-rac)-α-tocopherolj.
Lewis acids and mixtures of Lewis acids with Bronsted acids
Concerning the Lewis acids and/or mixtures of Lewis acids with Bronsted acids used as the catalyst under pressure in all PROCESSES 1 to 5B:
In principle all Lewis acids and mixtures of Lewis acids with Bronsted acids known to the person skilled in the art as catalysts for the condensation reaction of TMHQ or TMHQA with IP, PH or derivatives thereof can be used. Suitable catalysts are e.g. bortrifluoride (BF3), a mixture of boric acid (especially orthoboric acid) and oxalic acid, triflates and het- ero wolfram acids. Preferred are Lewis acids, where the radius of the metal cation varies from about 73 pm to about 90 pm, preferably from about 73 pm to about 82 pm, such as the radius of Fe2+ (0.74 A), Zn2+ (0.74 A), In3+ (0.81 A) and Sc3+ (0.73 A).
Especially suitable Lewis acids are indium(IE) salts such as indium(IE) halides, indium(EI) trifluoromethanesulfonate (= triflate) [In(SO3CF3)3; In(OTf)3] and indium(EI) bis(trifluoromethanesulfonamide) [In((NSO2CF3)2)3; In(NTf2)3]; scandium(IE) salts such as those described on page 5, line 14 to 21 in combination with page 6, line 23 to page 7, line 33 of EP 0 658 552 Al, e.g. scandium(IE) fluorosulfonate [Sc(SO3F)3], scandium(EI) triflate [Sc(OTf)3] and scandium(EI) fluorobenzenesulfonate [Sc(SO3C6H4F)3]; scan- dium(EI) bis(trifluoromethanesulfonamide) [Sc(NTf2)3], scandium(IE) nitrate [Sc(NO3)3], scandium(IE) sulfate [Sc2(SO4)3] and zinc(E) bis(trifluoromethanesulfonamide) [Zn(NTf2)2].
More preferred are InCl3, In(OTf)3 and Sc(OTf)3, whereby InCl3 is the most preferred one. The indium and scandium salts InCl3, In(OTf)3 and Sc(OTf)3 are known compounds which are commercially available, InCl3 e.g. from Fluka (No. 57 100), In(OTf)3 and Sc(OTf)3 e.g. from Aldrich (No.442 151 and 418 218). They can be used in solid form, anhydrous or hydrated (of which rnCl3'4 H2O is an example), as well as in solution or in suspension. For PROCESS 1 and 2 the catalyst is preferably dissolved or suspended in water. The concentration of such an aqueous solution is not critical* Furthermore, all the Lewis acids cited above tolerate acetic anhydride and other acylating agents as well as protic solvents such as acetic acid, methanol, ethanol and water. After the termination of the reaction the Lewis acids used as the catalysts can be recycled.
Especially suitable mixtures of Lewis acids with Bronsted acids are the following systems: zinc(E) compounds/hydrochloric acid, zinc(E) compounds (preferably ZnCl2)/gaseous HCl and Fe(E) chloride/gaseous HCl. The Fe(E) chloride can be prepared in situ by the reaction of Fe with HCl, which therefore presents an equivalent system to the system Fe(E) chloride/gaseous HCl. Suitable zinc(E) compounds are zinc(E) salts such as ZnCl2, ZnBr2 as well as all zinc(E) compounds which form ZnCl under the reaction conditions, e.g. ZnO. If the system ZnCl2/hydrochloric acid or ZnCl2/gaseous HCl is used, it is preferred to carry out the reaction in the presence of an amine such as disclosed in the last paragraph on page 4 and the first paragraph on page 5 of EP 0 100 471 Al, which is hereby incorporated by reference, or in the presence of an ammonium salt. Alternatively the reaction is preferably carried out by using the compound of the formula El or TV such as IP or PH having been pretreated with an amine or NH3 as described in DE-OS 26 06 830.
Manufacture of the starting materials
The starting material TMHQ Ac maybe obtained e.g. by selective hydrolysis of 2,3,5- trimethylhydroquinone diacetate as described in EP-A 1 239 045. 2,3,5-Trimethylhydro- quinone diacetate can be prepared e.g. by the acid catalyzed rearrangement of ketoiso- phorone in the presence of acetic anhydride or another acetylation agent as described in EP-A 0 850 910, EP-A 0 916 642, EP-A 0 952 137 or EP-A 1 028 103.
The (iso)phytyl compounds can be produced by conventional processes known to the per- son skilled in the art. Phytol and its derivatives represented by the formula IV with n = 3 can be used as E/Z-mixture as well as in pure E- or pure Z-form. Preferred is the use of phytol and its derivatives represented by the formula IV as E/Z-mixtures. The most preferred starting material selected from the (iso)phytyl compounds is IP. Of course any other appropriate isomeric form of the (iso)phytόl derivatives can also be used. (i?,i?)-phytol, (#,R,i?)-isophytol, (_S',i-,i?)-isophytol or (ftS',i?J?)-isophytol or an appropriate (iso)phytol derivative e.g. can be used to obtain (R,R)-PTMHQl(R,R)-?TMHQA or (RS,R,R)-TCPl(RSJiJi)-T PA, if TMHQ/TMHQA is used as the other component.
The other (di)(methyl)hydroquinones and compounds of the formula IE and IV with n being 0, 1 or 2 can be prepared by processes known to the person skilled in the art.
PROCESS 1. STEP a of PROCESS 2. STEP a of PROCESS 2a
As will be readily apparent, the use of the compound of the formula E with R1 = H (= TMHQ; = formula Ea with X1 , X2 and X3 = methyl and R3 = hydrogen) as a reactant in this process of the present invention will result in the production of a compound of the formula I with R1 = H such as PTMHQ (n = 3) while, when using a compound of the formula E with R1 = acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl (= TMHQA), especially TMHQ Ac, the respective compound of the formula I with R1 = acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl such as PTMHQA/PTMHQAc (n = 3) will be obtained.
If TMHQ/TMHQA is reacted with a compound of the formula IE and/or IV with n being 3 in both formulas, minor amounts of the isomers of PTMHQ/PTMHQA, (Z)- or(E)-2- (3,7,1 l,15-tetramethyl-hexadec-3-enyl)-3,5,6-trimethylhydroquinone (formula Va with Rl = hydrogen; see above)/(Z)- or(E)-3-(3,7,l l,15-tetramethyl-hexadec-3-enyl)-2,5,6-tri- methylhydroquinone- 1-alkanoate (formulaVa with R1 = acetyl, propionyl, pivaloyl, HO C- CH2-CH -CO, nicotinoyl or benzoyl; see above) and/or 2-[3-(4, 8,12-trimethyl-tridecyl)- but-3-enyl]-3,5,6-trimethylhydroquinone (formula Via with R1 = hydrogen; see above)/3- [3-(4, 8,12-trimethyl-tridecyl)-but-3-enyl]-2,5,6-trimethylhydroquinone-l-alkanoate (formula Via with R1 = acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl; see above) may be formed as by-products in PROCESS 1 as well as in STEP a of PROCESS 2 and 2A. If other compounds of the formula IE and/or IV are used where n = 0, 1 or 2, also minor amounts of compounds of the formula V and VI may be formed as byproducts.
Figure imgf000021_0001
Figure imgf000021_0002
PTMHQ/PTMHQA and their isomers represented by the formulae Va and Via (see above) are intermediates for the production of α-tocopherol or its alkanoates (final products).
Depending on the activity of the catalyst and the reaction conditions, the reaction proceeds to the final product (steps a and b of PROCESS 2) or is slowly enough so that these inter- mediates can be isolated (only step a of PROCESS 2 is performed). The same applies for the steps a and b of PROCESS 2a.
In a prefened embodiment of PROCESS 1 and PROCESS 2 TMHQ is reacted with PH and/or IP, more preferably with IP.
Conveniently the reaction is carried out under an inert gas atmosphere, preferably gaseous nitrogen or argon.
The reaction is preferably carried out at an absolute pressure of at least 1.1 bar, more pref- erably at an absolute pressure of from about 1.1 to about 20.0 bar, even more preferably at an absolute pressure of from about 1.1 bar to about 6.0 bar, even more, more preferably at an absolute pressure of from about 1.7 to about 5.1 bar, most preferably at an absolute pressure of from about 2.0 to about 3.6 bar.
The reaction temperature depends on the applied pressure and solvent because the reaction is carried out under reflux. Therefore, the reaction temperature is conveniently from about , 90°C to about 170°C, preferably from about 90°C to about 160°C, more preferably from ; about 112°C to about 160°C and most preferably from about 125 to about 150°C.
Suitable organic solvents are aprotic non-polar organic solvents such as aliphatic hydro- carbons, halogenated aliphatic hydrocarbons, aromatic hydrocarbons, halogenated aromatic hydrocarbons and mixtures thereof.
Preferred examples of aliphatic hydrocarbons are linear, branched or cyclic C5- to C15- alkanes. Particularly preferred are linear, branched or cyclic C6- to C10-alkanes, especially preferred are hexane, heptane, octane and cyclohexane or mixtures thereof.
Preferred examples of halogenated aliphatic hydrocarbons are mono- or polyhalogenated linear, branched or cyclic Ci- to C15-alkanes. Especially prefened examples are mono- or polychlorinated or -brominated linear, branched or cyclic C\- to C15-alkanes. More pre- ferred are mono- or polychlorinated linear, branched or cyclic - to C15-alkanes. Most prefened are 1,1,1-trichloroethane, 1,2-dichloroethane, methylene chloride and methylene bromide.
Prefened examples of aromatic hydrocarbons are benzene, toluene, o-, m- and p-xylene, 1,2,3-trimethylbenzene, mesitylene, pseudocumene, naphthalene and mixtures thereof, particularly prefened is toluene.
Prefened examples of halogenated aromatic hydrocarbons are mono-or polyhalogenated benzene. Especially prefened are chlorobenzene, 1,2-dichlorobenzene, 1,3-dichloro- benzene and 1,4-dichlorobenzene.
The most prefened non-polar solvents differ from catalyst to catalyst: If InCl3 is used as the catalyst, toluene and heptane are the prefened solvents; especially prefened is heptane. If Sc(OTf)3 is used as the catalyst, the most prefened solvent is tolu- ene. If the catalyst system Fe (FeCl2)/HCl(g) ("(g)" = gaseous) is used, the most prefened solvent is also toluene.
If the system ZnCl2/hydrochloric acid or ZnCl /HCl(g) ("g" = gaseous) is used, it is more prefened to carry out process 1 or step a) of process 2/2a in the presence of an amine such as disclosed in the last paragraph on page 4 and the first paragraph on page 5 of EP 0 100 471 Al, which is hereby incorporated by reference. The process can also be carried out by pretreating the compound of the formula IE or IV such as IP or PH with an amine or NH3 as described in DE-OS 26 06 830. If an amϋie is present in an amount of about 0.05 to about 5;0 weight%, preferably of about 0.1 to about 2.0 weight% - based on the weight of the compound IE or IV, whichever is employed, the most prefened solvent for carrying out the reaction with the Zn(E) catalyst system is hexane. If no amine is present, the most prefened solvent for carrying out the reaction with the Zn(E) catalyst system is heptane. The molar ratio of the compound of the formula E or Ea (most prefened: TMHQ or TMHQA(c)) to a compound of the formula IE or IV, whichever is employed, in the reaction mixture conveniently varies from about 0.95 : 1 to about 1 : 1.1, preferably from about 1 : 1.01 to about 1 : 1.05.
The amount of the aprotic non-polar organic solvent used is conveniently from about 0.1 ml to about 6.0 ml, preferably from about 0.15 ml to about 3.0 ml, based on 1 mmol of the compound of the formula IE or IV, whichever is employed.
The relative amount of catalyst, based on compound IE or IV, whichever is employed, is dependent on the catalyst system used and the reactants. Conveniently the relative amount of the catalyst based on compound IE or IV, whichever is employed, is at least 0.01 mol%. Generally the relative amount of catalyst varies from about 0.01 to about 30 mol%. The optimal relative amount of the catalyst is different from catalyst to catalyst and also depends on the reactants: If InCl3 is used as the catalyst, it may be preferably present e.g. in a relative amount of from about 0.1 mol% to about 2.5 mol%, especially preferable in a relative amount of from about 0.1 mol% to about 2.0 mol%, more preferably in a relative amount of from about 0.1 to about 1.0 mol%, even more preferably in a relative amount of from about 0.1 to about 0.5 mol%, based on compound IE or IV, whichever is employed. If Sc(OTf)3 is used as the catalyst, it may be preferably present in a relative amount of from about 0.05 mol% to about 2.0 mol%, preferably in a relative amount of from about 0.075 to about 1.5 mol%, more preferably in a relative amount of from about 0.1 to about 1.0 mol%, based on compound IE or IV, whichever is employed. If Fe and/or FeCl2 in combination with HCl is used as the catalyst, it may be present in an amount as described e.g. in DE - OS 21 60 103 (page 5, end of second paragraph and claim 9) and in US 3,789,086 (column 3, lines 27 - 60).
If Zn(E) and/or ZnCl2 is used as the catalyst, it may be present in an amount as described e.g. in.the examples 1 to 12 of US 2,411,967, in US 3,708,505 (page 1, right column, lines 26 - 44), in DE - OS 196 54 038 (page 2, lines 55 - 63; page 3, lines 4 - 6; page 3, line 60 to page 4, line 19; page 4, line 29 - 38), in EP-A 0 100471 (page 7, lines 19 - 24), in DE - OS 26 06 830 (page 4, last two lines to page 5, first two paragraphs), in US 4, 191, 692 (second column, lines 49 - 62).
In this context the expression "amount of catalyst" is to be understood as referring to the weight of pure Lewis acid or pure Bronsted acid present, even though the catalyst may be impure, in the form of an adduct with a solvent and/or a solution/suspension. The relative amount of the Bronsted acid depends also on the Lewis acid used and can be chosen accordingly.
The reaction can be carried out batchwise or continuously, and in general operationally in a very simple manner, for example (i) by adding the compound of the formula IE or IV - as such or dissolved in the solvent, preferably as such - portionwise or continuously to a mixture of the Lewis acid, the compound of the formula Ea/E (prefened: TMHQ or TMHQA; most prefened: TMHQ or TMHQ Ac) and the solvent. If a catalyst system consisting of a Lewis acid and a Bronsted acid is employed, the Bronsted acid is added continuously or batchwise, preferably continuously, to the mixture of the Lewis acid, the compound of the formula Ea/E (most prefened: TMHQ or TMHQA(c)) and the solvent.
It is also possible (ii) to add subsequently the Lewis acid, preferably as such or as aqueous solution, and the compound of the formula IE and/or IV - as such or dissolved in the non- polar solvent, preferably as such - to the compound of the formula Ea/E (most prefened: TMHQ or TMHQA(c)) and the solvent. The Bronsted acid is then continuously or batch- wise, preferably continuously, added to this mixture.
Conveniently, the compound of the formula IE or IV is added continuously to the compound of the the formula Ea/E (most prefened: TMHQ or TMHQA(c)) within about 15 to about 180 minutes, preferably within about 30 to about 150 minutes, more preferably within about 45 to about 130 minutes. The Lewis acid is preferably added at once, i.e. in its full amount, to the mixture of the compound of the formula Ea/E (most prefened: TMHQ or TMHQA(c)) and the solvent.
After completion of the addition of the compound of the formula IE or IV (in the non-polar solvent) the reaction mixture is suitably heated further at the reaction temperature for about 10 minutes to about 360 minutes, preferably for about 30 minutes to about 240 minutes. The working-up can be effected by procedures conventionally used in organic chemistry.
STEP b OF PROCESS 2, STEP b of PROCESS 2a
As will be readily apparent, the use of a compound of the formula E or Ea with R1 and R3, respectively, being hydrogen such as PTMHQ or an isomer thereof as a reactant in the process of this invention will result in the preparation of a tocol or a tocopherol such as α- tocopherol while, when using a compound of the formula E with R1 being acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl and n being 3 the respective to- cyl alkanoate or tocopheryl alkanoate such as α-tocopheryl alkanoate will be obtained.
For the manufacture of α-tocopherol or α-tocopheryl alkanoate PTMHQ or PTMHQ A and optionally one or more isomers thereof, which are obtained as minor by-products in the manufacture of PTMHQ or PTMHQ A, prepared to any method known to the person skilled in the art can be used as starting material.
This ring closure can be carried out using the same catalysts under substantially the same reaction conditions as described above for the reaction of compounds of the formula E (e.g. TMHQ: formula E with R1 = hydrogen; or TMHQA: formula E with R1 = acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl) or Ea with a compound of the formula IE and/or a compound of the formula . Therefore, in cases, where e.g. PTMHQ or PTMHQA and optionally one or more isomers thereof are produced according to STEP a, it is sufficient to simply prolong the reaction time of STEP a to realize STEP b, i.e. to prolong the reaction time for about 30 minutes to about 240 minutes, to increase the amount of catalyst and/or to increase the reaction temperature. PROCESSES 3 and 3a This reaction can be carried out using the same catalysts under substantially the same reaction conditions as described above for step a) of PROCESS 2 and 2a. Depending on the kind of catalyst, the amount of catalyst and the reaction temperature the reaction stops at the intermediates of the formula Ia/I or proceeds to the end products of the formula VE/VEa.
PROCESS 4 This reaction can be carried out using the same catalysts under substantially the same reaction conditions as described above for step a) of PROCESS 2 and 2a. The reaction proceeds to the final product of the formula X independent from the nature of the catalyst, the amount of catalyst and the reaction temperature.
PROCESS 5A
According to still another aspect of this invention, a compound of the formula VEc such as e.g. α-tocopherol or γ-tocopherol, or any other tocol as described in DE-OS 21 60 103 on page 5 in the third and forth paragraph may be converted into its alkanoate (a compound of the formula VEIa), e.g. its acetate, by treatment with an acylating agent in the presence of a Lewis acid as the catalyst at reduced pressure, preferably at an absolute pressure of below 0.9 bar, or under pressure, preferably at an absolute pressure of at least 1.1 bar.
More preferably the absolute reaction pressure varies from about 0.02 bar to about 0.9 bar (even more preferably from about 0.1 bar to about 0.9 bar, most preferably from about 0.2 bar to about 0.9 bar) and from about 1.1 bar to about 10.0 bar (even more preferably from about 1.1 bar to about 6.0 bar, even more, more preferably from about 1.1 bar to about 5.0 bar, most preferably from about 1.1 bar to about 3.0 bar).
Therefore, the invention is also directed to a process for the manufacture of tocyl alkanoates in the presence of a Lewis acid as the catalyst at reduced pressure, preferably at an absolute pressure of below 0.9 bar, or under pressure, preferably at an absolute pressure of at least 1.1 bar. The acylation in accordance with that aspect of the invention can be carried out using acy- lating agents conventionally used in the acylation of tocopherols such as anhydrides or halides.
Examples of these are anhydrides or halides of alkanoic acids such as acetic acid, propi- onic acid, pivalic acid, succinic acid, nicotinic acid and benzoic acid. Preferably, acetic anhydride or acid chloride, especially acetic anhydride, are/is used.
The molar ratio of the compound of the formula VEc to the acylating agent in the reaction mixture conveniently varies from about 1 : 1 to about 1 : 5, preferably from about 1 : 1 to about 1 : 3, more preferably from about 1 : 1.1 to about 1 : 2.
Suitable Lewis acids are the ones named above.
The amount of the Lewis acid used as the catalyst is based on the lesser molar amount of reactant, i.e. the compound of the formula VEc or the acylating agent, and can be in the range of from about 0.006 mol% to about 2.0 mol%, preferably from about 0.0075 mol% to about 1.5 mol%, more preferably from about 0.01 mol% to about 1.0 mol%, in the batchwise mode of operation. For continuous operation, the amount of catalyst will be ad- justed to the size of the reactor and the flow of the reactants. It will be appreciated that the determination of the appropriate figures based on the figures for batchwise operation is within normal skill. As in the other processes of the invention the Lewis acid is added at once, i.e. in its full amount. Preferably the catalyst is added as an aqueous, solution or suspension.
The temperature of the acylation is dependent on the catalyst system used and the temperature the reactants (resulting from former process steps) already have. The acylation reaction can be generally carried out at temperatures from about 20 to about 200°C, preferably from about 60 to about 180°C, more preferably from about 80 to about 160°C. When in- dium(IE) salts are used as the catalysts, the acylation reaction is preferably carried out at temperatures below 120°C, more preferably from about 15 to about 120°C, most preferably at room temperature, i.e. from about 15 to about 40°C. The reaction can be carried out essentially in the absence of an additional organic solvent, which is prefened.
"Essentially in the absence of an additional organic solvent" in the context of the present invention means that essentially no organic solvent is present during the reaction and that no organic solvent is deliberately added. It might, however, be possible that traces of organic solvent are present in the starting materials or the catalyst as impurities. In other words, the reaction is carried out in substance; i.e. no other compound except the compound of the formula VEc, the acylating agent and the catalyst is intendedly used for the reaction, so that at the beginning of the reaction the amount of any substance except for the starting material, the compound of the formula VEc and the acylating agent, and except for the catalyst in the reaction mixture is < 5 weight%, preferably < 3 weight%, more preferably < 0.5 weight%, and that no further compound is added during the reaction
Alternatively it is also possible to carry out the reaction in the presence of an additional organic solvent, e.g. pyridine.
The reaction is conveniently carried out under an inert gas atmosphere, preferably gaseous nitrogen or argon.
It is a particular feature of the acylation according to the present invention that when using chiral tocols and tocopherols, e.g. (enantiomeric pure) (R,R,R)-α-tocopherol, the acylation proceeds substantially without epimerization in the presence of indium(IE) salts as the catalysts and at a temperature below 120°C, e.g. from about 20°C to about 120°C. Thus, if e.g. (i?,i?,R)-α-tocopherol is used as starting material for PROCESS 5A, (R,R,R)- - tocopheryl alkanoate is obtained.
In especially prefened embodiments of PROCESS 5A α-tocopherol (formula VEb with n = 3; see above), β-tocopherol (formula VE c with X1 = X3 = CH3, X2 = H and n = 3), γ- tocopherol (formula VE c with X2 = X3 = CH3, X1 = H and n = 3) and δ-tocopherol (for- mula VE c with X1 = X2 = H, X3 = CH3 and n = 3), preferably α-tocopherol and β- tocopherol, more preferably α-tocopherol, are/is acylated to the appropriate tocopheryl alkanoates (compounds of the formula VIE/VEIa with n = 3 and R, X1, X2 and X3 having the same meanings and preferences as above). More prefened the appropriate acetates are manufactured, especially with indium(ET) salts (preferences see above) as the catalysts and at a temperature below 120°C, preferably at room temperature, i.e. a temperature between 15 and 40°C.
PROCESS 5B
It can be carried out using the same catalysts under substantially the same reaction conditions as described above for PROCESS 5A.
Process for the manufacture of formulations of α-tocopherol or its alkanoates The α-tocopherol or its alkanoate obtained by one of the processes of the present invention can further be formulated by any method known to the person skilled in the art, e.g. as those disclosed in US 6,162,474, US 2001/0009679, US 6,180,130, US 6,426,078, US 6,030,645, US 6,150,086, US 6,146,825, US 6,001,554, US 5,938,990, US 6,530,684, US 6,536,940, US 2004/0053372, US 5,668,183, US 5,891,907, US 5,350,773, US 6,020,003, US 6,329,423, WO 96/32949, US 5,234,695, WO 00/27362, EP 0 664 116, US
2002/0127303, US 5,478,569, US 5,925,381, US 6,651,898, US 6,358,301, US 6,444,227, WO 96/01103 and WO 98/15195.
The following Examples illustrate the invention further.
Examples
In the following examples minor amounts of the following by-products were obtained:
PTMQ: phytyltrimethylquinone:
Figure imgf000029_0001
PTD: phytadienes = dehydrated by-products of IP (easily separable);
BZF: benzofuranes:
Figure imgf000030_0001
Phytyl-toluene compounds and their double-bond isomers (easily separable):
Figure imgf000030_0002
The analysis of the products was done by gas chromatography (GC) using an internal standard.
Jeffsol EC50® is a solvent mixture available from Huntsman Corp., PO Box 15730 Aus- tin, Texas, USA/Antweφ 2030, Belgium, which consists of ethylene carbonate and propylene carbonate in the volume ratio 1 : 1.
If examples were carried out at "atmospheric pressure" (comparative examples), this indicates that the reaction was carried out at a pressure from about 0.96 bar to about 1.03 bar.
Examples 1-32; Processes with InCh or In(OTf as the catalyst Examples 1-14; Preparation of PTMHQ
Examples 1-3: InCl3 as the catalyst 12.88 mmol of TMHQ and 8.58 mmol of IP were reacted in the solvent or solvent system given in Table 1 in the presence of InCl3 as the catalyst (amounts of the catalyst given in Table 1) and at atmospheric pressure. The reaction time was 2 hours. For further details and the results see Table 1. Examples 4 and 5: In(QTfh as the catalyst 12.88 mmol of TMHQ and 8.58 mmol of IP were reacted in a mixture of 20 ml of heptane and 20 ml of Jeffsol EC 50® in the presence of increasing amounts (see Table 1) of In(OTf)3 as the catalyst and at atmospheric pressure. For further details about the reaction conditions and the results see Table 1.
Table 1: The amount of THMQ was 12.88 mmol in all cases, the amount of IP was 8.58 mmol in all cases.
Figure imgf000031_0001
Examples 6 and 7: InC as the catalyst Varying amounts of TMHQ were reacted with 17.17 mmol of IP in 45 ml of toluene at 110°C in the presence of 1.0 mol% of InCl3 - based on IP - as the catalyst and at atmos- pheric pressure. Further details and the results are presented in Table 2.
Example 8: In(OTfh as the catalyst TMHQ (38.63 mmol) and IP (25.75 mmol, 97%, added during 1 hour) were reacted in a : molar ratio of 1.5 : 1 in the presence of 1.0 mol% of frι(OTf)3 as the catalyst (amount based on IP) at 22°C and at atmospheric pressure. For further details and the results see Table 2. After separation of the heptane phase and washing of the. heptane phase with Jeffsol EC50® (60 ml) the resulting mixture (suspension in heptane) was filtered under vacuum. The pasty nearly colorless solid was analysed by GC.
Example 9: In(OTfh as the catalyst TMHQ (24.691 g, 161.1 mmol) and'ff (38.833 ml, 107.4 mmol, 97%, added during 1 hour) were reacted in a molar ratio of 1.5 : 1 in the presence of 1.0 mol% of In(OTf)3 as the catalyst (amount based on IP) at 22°C and at atmospheric pressure. For further details and the results see Table 2. After separation of the heptane phase and washing of the heptane phase with Jeffsol EC50® (250 ml) the resulting suspension in heptane was filtered under vacuum. The pasty nearly colorless solid was analysed by quantitative GC.
Table 2: The amount of catalyst was 1.0 mol% - based on IP - in all cases.
Figure imgf000032_0001
Examples 10-14 200 mmol of TMHQ were reacted with 200 mmol of IP (examples 10 and .13) and 203 mmol of IP (examples 11, 12 and 14), respectively, in the presence of increasing amounts of frι(OTf)3 (example 10) or rnCl3 (examples 11-14) as the catalyst in 100 ml of an organic solvent. Examples 10 and 14 were carried out under pressure, whereby examples 11-13 were carried out at atmospheric pressure. For the reaction temperature, the pressure, the reaction time and the type of solvent see Table 3.
Table 3: The amount of solvent was 100 ml in all cases. The amount of TMHQ was 200 mmol in all cases. In the examples 11', 12 and 14 a molar excess of IP of 1.5 mol% based on the amount of TMHQ was used. The yield of PTMHQ is based on IP.
Figure imgf000033_0001
Examples 15-29: Preparation of (all-mcVTCP Examples 15-16: Preparation of (all-rαc -TCP at atmospheric pressure
In a 250ml Biichi reactor or an autoclave equipped with a stiner, a thermometer, a pressure indicator, a Dean-Stark separator, and a reflux condenser 30.447 g (200 mmol) of TMHQ (99.97%), certain amounts of hιCl3 (see Table 4; amounts based on IP) and 100 ml of toluene were heated at 114°C under a continuous nitrogen flow and under an absolute pressure of 1.0 bar. 74.035 ml (200 mmol) of IP (94.6%) were added at a feed rate of 1.234 ml per minute. Approximately 3.6 ml water were collected until the end of the reaction. After completion of the addition the reaction mixture was stined for 1 hour at 114°C and cooled down to room temperature. The reaction mixture was concentrated under reduced pressure (45°C at 95 to 15 mbar). (all-rac)-TCP was obtained as a viscous oil. For the results see Table 4.
Examples 17-18: Preparation of (all-rαc)-TCP under pressure
Examples 15 and 16 were repeated, but the reaction was carried out at 137°C under an absolute pressure of 2 bar. After 1 hour at 137°C the reaction mixture was cooled down to room temperature and once, at room temperature the pressure was released. For the results see Table 4, 5 (example 18 only) and 12 (example 18 only).
Example 19: Preparation of (all-rac -TCP under pressure
In a 250ml Bϋchi reactor or an autoclave equipped with a stiner, a thermometer, a pressure indicator, a Dean-Stark separator, and a reflux condenser, 30.447 g (200 mmol) of TMHQ (99.97%,), 5 ml of InCl3 (0.2 M aqueous solution, 0.5 mol%, 1 mmol) and 100 ml of heptane were heated at 147°C under a continuous nitrogen flow and under an absolute pressure of 3.4 bar. 75.304 ml (203 mmol) of IP (94.6%) were added at a feed rate of 0.605 ml per minute. Approximately 3.6 ml water were collected until the end of the reaction. After completion of the addition the reaction mixture was stined for 1 hour at 147°C and cooled down to room temperature. Then the pressure was released. The reaction mixture was concentrated under reduced pressure (45°C at 110 to 15 mbar). (all-rac)-TCP was obtained as a viscous oil (91.51 g). The yield was 92.0% - based on IP. For the results see Table 4, 6, 7, 8 and 12.
Table 4: Comparison between experiments at atmospheric pressure and under pressure in toluene with InCl3 as the catalyst. The conversion of IP was 100% in all cases.
Figure imgf000034_0001
Figure imgf000035_0001
Examples 20 and 22 (*); Preparation of (all-røc)-TCP with InCU as the catalyst in different solvents and under pressure
200 mmol of TMHQ and 203 mmol of ff (conesponding a molar excess of 1.38 mol% - based on the amount of TMHQ) were reacted in 100 ml of toluene at 137°C or in 100 ml of heptane at 147°C. The IP was added during 120 minutes. Afterwards the mixture was reacted for further 60 minutes. All yields and selectivities (given in Table 5) are based on IP. See also Table 6.
Examples 21, 23 and 24: Preparation of (all-rαcVTCP with different amounts of indium salts as the catalyst and under pressure
200 mmol of TMHQ and 200 mmol of IP were reacted in 100 ml of toluene at 137°C or in 100 ml of heptane at 147°C. The IP was added during 60 minutes. Afterwards the mixture was reacted for further 60 minutes. All yields and selectivities (given in Table 5) are based on ff.
Table 5: Influence of the counterion of the indium salt. The amount of catalyst was 2.0 mol%, based on IP, in all cases. The conversion of IP was 100% in all cases. * molar ex- cess of IP of 1.38%
Figure imgf000035_0002
With frιCl3 excellent yields were obtained in both solvents, heptane and toluene. The selectivity for the formation of the desired 6-membered ring product (all-rac)-TCP with this catalyst was very high compared to results with In(OTf)3 as a difference of 28 to 30% for the selectivity was observed.
It was also found that in heptane a small excess of ff (+1.38 mol%) led to a much better yield (see Table 5, example 22) than carrying out the reaction with equimolar amounts of ff and TMHQ. In fact, (all-røc)-TCP could be isolated in 93.9% yield after work-up. It has to be emphasized that at atmospheric pressure a TMHQ/IP ratio of 1.5/1 had to be used whereas, under pressure, an equimolar ratio was sufficient to produce the desired chroman ring compound (all-røc)-TCP in excellent yield.
It is noteworthy that the proportion of TMHQ used for these reactions under pressure was twenty-fold higher than at atmospheric pressure (4 mol L instead of 0.2 mol/L) and it did not affect the yield of the reaction.
Example 25: Preparation of (all-rac -TCP with InCl3 as the catalyst and under pressure 200 mmol of TMHQ and 203 mmol of ff were reacted in 100 ml of toluene at 137°C. The ff was added during 120 minutes. The reaction mixture was then further reacted for an- other 60 minutes. The yield - based on IP - is given in Table 6. See also Table 7.
Example 26: Preparation of (all-rac -TCP with InCl3 as the catalyst and under pressure 200 mmol of TMHQ and 203 mmol of ff were reacted in 100 ml of toluene at 137°C. The ff was added during 120 minutes. The reaction mixture was then reacted for further 566 minutes. The yield - based on IP - is given in Table 6.
Example 27: Preparation of (all-rac)-TCP with InCl3 as the catalyst and under pressure 200 mmol of TMHQ and 203 mmol of ff were reacted in 100 ml of heptane at 147°C. The ff was added during 120 minutes. The reaction mixture was then further reacted for an- other 120 minutes. The yield - based on IP - is given in Table 6.
Table 6: Influence of the amount of InCl3. The conversion of ff was 100% in all cases.
Figure imgf000037_0001
When the amount of InCl3 was reduced to 0.25 mol% (all-rac)-TCP was still obtained in good yield (see Table 6, examples 26 and 27). However a longer reaction time (e.g. up to 566 minutes in toluene, example 26) was needed to obtain nearly total ring closure.
It appeared that best results were obtained (selectivity (yield)) for (all-røc)-TCP using a catalyst amount of 0.5 mol% to 2 % InCl3, especially in heptane. In toluene and in heptane, the desired chroman product (all-rac)-TCP could be isolated in 90.2 up to 96.0% yield.
Example 28: Preparation of (all-racVTCP in cyclohexane at an absolute pressure of 4.0 bar 200 mmol of TMHQ and 203 mmol of ff were reacted in 100 ml of cyclohexane at 135°C and under an absolute pressure of 4.0 bar in the presence of 0.5 mol% of LιCl3 - based on ff. The ff was added during 120 minutes. Afterwards the mixture was reacted for further 380 minutes. The yield of (all-rac)-TCP given in Table 7 is based on IP.
Example 29: Preparation of (all-rac)-TCP in hexane under pressure
200 mmol of TMHQ and 203 mmol of IP were reacted in 100 ml of hexane in the presence of 0.5 mol% of InCl3 - based on ff. The ff was added during 120 minutes at 125°C and under an absolute pressure of 4.0 bar. Afterwards the mixture was reacted for further 180 minutes at 125°C and under an absolute pressure of 4.0 bar and further 206 minutes at 135°C and under an absolute pressure of 5.1 bar. The yield of (all-rac)-TCP given in Table 7 is based on IP.
Table 7: Influence of the solvent. The conversion of ff was 100% in all cases.
Figure imgf000038_0001
One of the advantages of heptane compared to toluene was the absence of by-products such as phytyl-toluene compounds due to the solvent.
Examples 19(-a -19-e: Reproducibility
All reactions were carried out in 100 ml of heptane with 200 mmol of TMHQ, 203 mmol of ff, 0.5 mol% of InCl3 under an absolute pressure of 3.4 bar and at 147°C. ff as added within 120 minutes. The reaction time was 60 minutes. AU yields are based on IP. The results are summarized in Table 8.
Table 8: Test of reproducibility, total conversion of ff:
Figure imgf000038_0002
An excellent reproducibility was found as only a 1.04% maximum variation of the yield was observed with an average yield of 91.6% over five experiments. Examples 30-37: Processes with ScfOTfh as the catalyst
Examples 30-31; Preparation of (all-mcVTCP with azeotropic removal of water
In a Bϋchi reactor with a Dean-Stark separator 200 mmol of TMHQ and 200 mmol of ff were reacted in 100 ml of toluene in the presence of 0.1 mol% of Sc(OTf)3 - based on IP.
The IP was added during 60 minutes at the temperature and at the pressure given in Table
9. Afterwards the mixture was reacted for further 60 minutes at the same temperature and pressure. The yield and selectivity of (all-rac)-TCP given in Table 9 is based on ff.
Example 32: Preparation of (all-rac)-TCP without azeotropic removal of water In an autoclave reactor 200 mmol of TMHQ and 200 mmol of ff were reacted in 100 ml of toluene in the presence of 0.1 mol% of Sc(OTf)3 - based on ff. The ff was added during 60 minutes at an absolute pressure of 3.6 bar and at a temperature of 140°C. Afterwards the mixture was reacted for further 60 minutes at the same temperature and pressure. The yield and selectivity of (all-rac)-TCP given in Table 9 is based on ff.
Example 33: Preparation of (all-røc -TCP without azeotropic removal of water
In a 250 ml autoclave reactor equipped with a mechanical stiner, a thermometer and a pressure indicator 34.396 g (221 mmol) of TMHQ (98%), 1 mmol of Sc(OTf)3 (0.5 mol% - based on IP) and 50 ml of toluene were heated at 140°C under nitrogen atmosphere and under an absolute pressure of 5.6 bar. 72.350 ml (200 mmol) of ff (97%) were added at a feed rate of 2.412 ml per minute. After completion of the addition the reaction mixture was stined for one hour at 140°C, cooled down to room temperature and when room tempera- ture was reached the pressure was released. The reaction mixture was concentrated under reduced pressure (45°C at 95 to 15 mbar). A viscous oil (94.76 g) was obtained and analysed by quantitative GC. The yield of (all-r c)-TCP was 81.4% - based on IP.
Examples 34 and 35: Preparation of fall-rac -TCP with azeotropic removal of water Examples 30 and 31 were repeated, but instead of 0.1 mol% of Sc(OTf)3 1.0 mol% of Sc(OTf)3 were used. The yield and selectivity of (all-røc)-TCP, based on IP, is given in Table 9. Example 36 Example 35 was repeated but the reaction was carried out at a higher temperature and at a higher pressure. For details and the results see Table 9 and 12.
5 Example 37: Preparation of fall-rac -TCP without azeotropic removal of water Example 32 was repeated, but instead of 0,1 mol% of Sc(OTf)3 1.0 mol% of Sc(OTf)3 were used. The yield and selectivity of (all-r c)-TCP, based on IP, is given in Table 9.
Table 9: Comparison between experiments at atmospheric pressure and under pressure in 10 toluene with Sc(OTf) as the catalyst.
Figure imgf000040_0001
15 Examples 38-47: Processes with Fe/HCl as the catalyst Example 38: Preparation of (all-mcVTCP in a Bϋchi reactor
In a 500 ml Biichi reactor equipped with a stiner, a thermometer, a pressure indicator, a Dean-Stark separator and a reflux condenser 91.3 g (595 mmol) of TMHQ (99.5%), 0.16 g 20 (2.86 mmol) of iron powder and 137 g of toluene were heated to 140°C under a continuous argon flow and under an absolute pressure of 1.9 bar. When the temperature of the reaction mixture was 140°C hydrogen chloride was added to the reaction mixture at a feed rate of 0.333 g per minute for the next 5 hours (30 minutes of saturation, 4 hours addition of ff and 30 minutes further reaction afterwards; altogether 100 g -of gaseous HCl were used during these 5 hours). After 30 minutes under hydrogen chloride flow at 136°C and under an absolute pressure of 2.05 bar, 187.9 g (616 mmol) of ff (97.5%) were added at a feed rate of 0.78 g per minute. During the addition of ff (4 hours) the temperature of the reaction mixture increased from 136°C to 146°C. Approximately 14 ml of aqueous phase were collected until the end of the reaction. After the addition of ff was completed the reaction mixture was stined for further 30 minutes at 146°C, then the hydrogen chloride flow was stopped, replaced by an argon flow and the solution was cooled down to room temperature. When room temperature was reached the pressure was released. The reaction mixture was concentrated under reduced pressure (45°C at 95 to 15 mbar). A viscous oil (270.2 g) was obtained and analysed by quantitative GC. The yield of (all-rac)-TCP was 91.5% - based on ff.
Examples 39-42: Preparation of (all-racVTCP under pressure
Example 38 was repeated with the same amounts of TMHQ, ff and Fe. The amount of HCl and the time for the addition of ff were, however, different. The pressure, under which the reaction was carried out was also slightly different in the examples 39-41. For further details and the results see Table 10 and 13 (examples 41 and 42 only).
Examples 43-46: Preparation of (all-mc -TCP at atmospheric pressure In a Bϋchi reactor with a Dean-Stark separator 600 mmol of TMHQ and varying amounts of ff (see Table 10) were reacted in 137 g of toluene (only example 48 and 49: 171.1 g toluene) in the presence of varying amounts of iron powder and fed gaseous HCl (see Ta- ble 10). The gaseous HCl was added with a feed rate of 0.333 g per minute to the TMHQ in toluene. The mixture of TMHQ and toluene was saturated with HCl during 30 minutes before the ff was added during the time given in Table 10 and at an absolute pressure of 1.0 bar under a continuous HCl flow. After the complete addition of ff the mixture was reacted for further 30 minutes at the same temperature and pressure and the continuous HCl flow. Then the HCl flow was stopped and the reaction mixture worked-up. The yield and selectivity of (all-rac)-TCP given in Table 10 is based on ff. Example 47: Preparation of fall-racVTCP under pressure
Example 46 was repeated but the reaction was carried out under an absolute pressure of 2.1 bar instead of 1.0 bar. Further details and the results are shown in Table 10.
Table 10: Comparison between experiments at atmospheric pressure (examples 43 - 46) and under pressure (examples 38 - 42 and 47) in toluene (under reflux) with Fe/HCl as the catalyst; the conversion of ff was 100% in all cases. All yields and selectivities are based on ff.
Figure imgf000042_0001
Examples 48-53: Processes with ZnCh/HCl as the catalyst
Example 48: Preparation of (all-r c)-TCP in heptane in the absence of an amine at atmospheric pressure 322, mmol of TMHQ and 320 mmol of IP were reacted, in 163.3g of heptane under reflux in the presence of ZnCl2 and gaseous HCl as the catalyst (amounts see Table 11). The reaction was carried out at 1.0 bar. Further details and the results are given in Table 11.
Example 49: Preparation of (all-racVTCP in heptane in the absence of an amine under pressure
Example 48 was repeated, but the reaction carried out under an absolute pressure of 2.1 bar and not at 1.0 bar. Further details and the results are given in Table 11.
Example 50: Preparation of (all-rαc)-TCP in hexane in the presence of an amine under pressure
In a 500 ml Biichi reactor equipped with a stiner, a thermometer, a pressure indicator, a Dean-Stark separator and a reflux condenser 60 g (394 mmol) of TMHQ (99.5%), 12.5 g (91.7 mmol) of ZnCl2, 1.2 g of tridecylamine and 177.7 g of hexane were heated to 92°C under a continuous argon flow and under an absolute pressure of 2.2 bar. When the temperature of the reaction mixture had reached 92°C gaseous hydrogen chloride was added to the reaction mixture at a feed rate of 0.035 g per minute to saturate the reaction mixture with HCl. (The HCl flow was continued during the addition of IP and the further reaction time, i.e. gaseous HCl was added during 2.5 hours.) After 30 minutes under hydrogen chlo- ride flow at 94°C and at an absolute pressure of 2.2 bar, 122.6 g (403 mmol) of ff (97.5%) were added at a feed rate of 2.05 g per minute. During the addition of ff the temperature of the reaction mixture increased from 94°C to 100°C. Approximately 7.4 ml of an aqueous phase were collected until the end of the reaction. After all ff was added the reaction mixture was stined for further 60 minutes at 102°C, then the hydrogen chloride flow was stopped (A total of 5.3 g of hydrogen chloride were used during the 2.5 hours.), replaced by an argon flow and the solution was cooled down to room temperature. When room temperature was reached, the pressure was released. The reaction mixture was concentrated under reduced pressure (45°C at 110 to 15 mbar). A viscous oil (176.88 g) was obtained and analysed by quantitative GC. The yield of (all-rαc)-TCP was 94.9% - based on ff.
Example 51: Preparation of (all-rαcVTCP in hexane in the presence of an amine under pressure Example 50 was repeated, but instead of 403 mmol of ff 404 mmol of ff were added and instead of 5.3 g of gaseous HCl 49.9 g of gaseous HCl were used. For further details- and the results see Table 11.
Example 52: Preparation of (all-mcVTCP in hexane in the presence of an amine at atmospheric pressure
Example 51 was repeated with the amounts of TMHQ, ff, ZnCl2, tridecyl amine and gaseous HCl given in Table 11. The reaction, however, was not carried out at 2.2 bar, but at 1.0 bar. The results are presented in Table' 11.
Example 53: Preparation of (all-mcVTCP in heptane in the presence of an amine at atmospheric pressure
Example 51 was repeated with the amounts of TMHQ, ff, ZnCl2, tridecyl amine and gaseous HCl given in Table 11. The reaction, however, was not carried out in hexane, but in heptane. The results are presented in Table 11 and 13.
Table 11: Comparison between experiments at atmospheric pressure (1.0 bar) and under pressure (2.1 - 2.2 bar) in heptane under reflux (examples 48, 49 and 53) or hexane under reflux (examples 50-52) with ZnCl2/HCl(g) as the catalyst, ff was added during one hour in all cases. All yields and selectivities are based on ff. The conversion of ff was 100% in all cases.
Figure imgf000044_0001
Examples 18, 19-d.23,: Amount of by-products For these five experiments the precise analytical data concerning the by-products are given in Table 12.
Table 12: Detailed results and comparison of selectivity for Lewis acids as the catalyst.
Figure imgf000045_0001
As already stated, fr Cl3 shows a higher selectivity for the formation of TCP than frι(OTf)3 and Sc(OTf)3. Table 13: Detailed results and comparison of selectivity for a mixture of Bronsted with Lewis acids as the catalyst
Figure imgf000046_0001
Example 54: Preparation of (all-rac,-3,4-dehydro-α-tocopherol
15.22 g (99.2 mmol) of TMHQ (99.2%), 29 mg (0.5 mmol) of iron powder and 70 ml of toluene were added to a 200 ml flask equipped like the Biichi reactor and the resulting beige suspension was stined at 750 rounds per minute. The reaction mixture was heated to 111°C at a constant heating rate of 2 K per minute. HCl was added at a flow rate of 33.8 ml per minute and argon was added at a flow rate of 3.5 ml per minute. After 45 minutes the reaction temperature of 111°C had been reached and 31.01 g (102.4 mmol) of 1,2- dehydroisophytol (97.3%; from Teranol in Lalden, Switzerland) were added at a feed rate of0.138 g per minute during 225 minutes. During the addition of the 1 ,2-dehydroisophytol toluene was slowly distilled off in order to keep the volume of the solution constant during all the reaction. The reaction temperature also increased from 111°C to 157°C. After completion of the addition of 1,2-dehydro-isophytol the reaction mixture was stined at this temperature for 45 minutes and cooled down to room temperature. When the heating was switched off, the HCl flow was stopped and replaced by a stronger argon flow. After 1 hour the temperature of the reaction mixture was 60°C. The reaction mixture was then concentrated under reduced pressure (60°C at 300 to 18 mbar). The resulting oil was further concentrated under reduced pressure (60°C at 0.3 to 0.1 mbar) during more than 2 hours to yield the crude product (45.6 g). A qualitative GC analysis of the crude product showed that it contained mainly TMHQ (25.6%) and (all-rαc)-3,4-dehydro- -tocopherol (21.1%). The crude product was purified by two successive column chromatographies (first with ethyl acetate/hexane = 1/9 (v/v; silica gel 60 (Merck), particle size 0.063 - 0.2 mm) and finally with ethyl acetate/hexane = 1/19 (v/v)) to yield (all-rαc)-3,4-dehydro-α- tocopherol (5.23 g, GC 81.7%, 10.0% isolated yield, 44.1% yield based on conversion).

Claims

Claims
1. A process for the alkenylation of phenols comprising 0 to 4 methyl groups, a total of 1 to 3 hydroxy groups and at least one unsubstituted position, whereby the unsubstituted position is ortho to a hydroxy group, with a compound of the formula IE and/or IV
Figure imgf000048_0001
with R being hydroxy, acetyloxy, benzoyloxy or halogen, n being an integer from 0 to 3, and whereby the reaction is carried out in an organic solvent in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure.
The process as claimed in claim 1, wherein the phenol has the formula Ea
Figure imgf000048_0002
with X1, X2 and X3 being independently from each other hydrogen or methyl and R3 being hydrogen, acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl, with the proviso that R3 is only acetyl, propionyl, pivaloyl, HO2C-CH2- CH2-CO, nicotinoyl or benzoyl, if X1, X2 and X3 are all methyl.
3. The process as claimed in claim 1, wherein the phenol has the formula E
Figure imgf000049_0001
(ll)
with R1 being hydrogen, acetyl, propionyl, pivaloyl, HO2C-CH -CH2-CO, nicotinoyl or benzoyl.
4. A process for the manufacture of compounds of the formula VEa by
Figure imgf000049_0002
(Vila) a) (STEP a) optionally reacting a compound of the formula Ea
Figure imgf000049_0003
with a compound of the formula IE and/or IV in an organic solvent
Figure imgf000049_0004
b) (STEP b) submitting in an organic solvent a compound of the formula la
Figure imgf000050_0001
and optionally one or more double bond isomers thereof, all obtainable by step a), to ring closure to form chroman derivatives VEa,
with R2 being hydroxy, acetyloxy, benzoyloxy or halogen, R3 being hydrogen, acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl,
X1, X2 and X3 being independently from each other hydrogen or methyl, with the proviso that R3 is only acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl, if X1, X2 and X3 are all methyl, and n being an integer from 0 to 3,
whereby at least one of the steps a) and b) is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure.
5. A process for the manufacture of chroman derivatives VEa
Figure imgf000050_0002
(Vila) by reacting of phenols comprising 0 to 4 methyl groups, a total of 1 to 3 hydroxy groups and at least one unsubstituted position, whereby the unsubstituted position is ortho to a hydroxy group, with a compound of the formula IE and/or IV
Figure imgf000051_0001
with R being hydroxy, acetyloxy, benzoyloxy or halogen, and n being an integer from 0 to 3, whereby the reaction is carried out in an organic solvent in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure.
6. The process as claimed in any of the preceding claims, wherein n in the formula IE and IV is 3.
7. A process for the manufacture of alkanoates of the formula VEIa,
Figure imgf000051_0002
(Villa) by reacting compounds of the formula VIIc,
Figure imgf000051_0003
(VIIc) with an appropriate acylating agent, wherein n is an integer from 0 to 3, X1, X2 and X3 are independently from each other hydrogen or methyl, and R is selected from the group consisting of acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl, and benzoyl, . characterized in that the reaction is carried out in the presence of a Lewis acid as the catalyst at reduced pressure or under pressure.
8. The process as claimed in claim 7, wherein X1, X2 and X3 are methyl and n = 3.
- 9. The process as claimed in any of the preceding claims characterized in that the Lewis acid used as the catalyst is indium trichloride, indium tribromide, indium triiodide, indium triacetate, indium tris[bis(trifluoromethanesulfonamide)], indium triflate or scandium triflate.
10. The process as claimed in any of the preceding claims characterized in that the mixture of a Lewis acid and a Bronsted acid used as the catalyst is a mixture of ZnCl2 with HCl or Fe and/or FeCl2 with HCl.
11. The process as claimed in claim 8 characterized in that the α-tocopherol used (for- mula VEc with X1 = X2 = X3 = methyl and n = 3) is the reaction, mixture obtained by step b) of the process according to claim 4.
12. The process according to claim 4 characterized in that all steps are carried out under pressure.
13. The process according to one or more of claims 1 to 6 and according to one or more of claims 9 to 12 as far as they refer to one or more of the claims 1 to 6, characterized in that the organic solvent is a non-polar aprotic organic solvent.
14. The process according to claim 13 characterized in that the non-polar aprotic organic solvent is selected from the group consisting of cyclohexane, hexane, heptane, octane, 1,1,1-trichloroethane, 1,2-dichloroethane, methylene chloride, methylene bromide, benzene, toluene, o-xylene, m-xylene, p-xylene, chlorobenzene, 1,2-dichlorobenzene, 1,3-dichlorobenzene and 1,4-dichlorobenzene.
15. A process for the manufacture of alkanoates of α-tocopherol, β-tocopherol, γ- tocopherol and δ-tocopherol, preferably of alkanoates of α-tocopherol, more preferably of α-tocopherol acetate, wherein an α-tocopherol, β-tocopherol, γ-tocopherol and δ-tocopherol, respectively, obtained by a process according to any one of the preceding claims is reacted with an acylating agent.
16. A process for the manufacture of alkanoates of α-tocopherol, β-tocopherol, γ- tocopherol and δ-tocopherol by reacting αrtocopherol, β-tocopherol, γ-tocopherol and δ-tocopherol, respectively, with an acylating agent selected from the group consisting of the anhydrides and halides of acetic acid, propionic acid, pivalic acid, succinic acid, nicotinic acid, and benzoic acid, characterized in that the reaction is carried out in the presence of an indium(ET) salt as the catalyst, preferably at temperatures below 120°C.
17. A process for the manufacture of formulations of α-tocopherol, β-tocopherol, γ- tocopherol, δ-tocopherol or their alkanoates, preferably of α-tocopherol or its alkanoates, whereby α-tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol or their alkanoates, respectively, preferably α-tocopherol or its alkanoates, obtained by a process according to one or more of the preceding claims are used.
18. A process for the manufacture of a compound of the formula X
Figure imgf000053_0001
(X) by reacting a compound of the formula E
Figure imgf000054_0001
with a compound of the formula IX
Figure imgf000054_0002
in an organic solvent with R1 being hydrogen, acetyl, propionyl, pivaloyl, HO2C-CH2-CH2-CO, nicotinoyl or benzoyl R2 being hydroxy, acetyloxy, benzoyloxy or halogen, and n being an integer from 0 to 3, whereby the reaction is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure.
19. A process for the manufacture of compounds of the formula X with R being acetyl, propionyl, pivaloyl, HO2C-CH2-CH -CO, nicotinoyl or benzoyl,
Figure imgf000054_0003
(X) by reacting a compound of the formula X with R1 being hydrogen with an appropriate acylating agent, wherein n is an integer from 0 to 3, characterized in that the reaction is carried out in the presence of a Lewis acid as the catalyst at reduced pressure or under pressure.
PCT/EP2004/013771 2004-06-11 2004-12-03 PROCESS FOR THE MANUFACTURE OF CHROMAN DERIVATIVES, ESPECIALLY α-TOCOPHEROL AND ALKANOATES THEREOF WO2005121115A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP04803493.8A EP1778661B1 (en) 2004-06-11 2004-12-03 Process for the manufacture of chroman derivatives, especially alpha-tocopherol and alkanoates thereof
JP2007526211A JP4999690B2 (en) 2004-06-11 2004-12-03 Method for producing chroman derivatives, in particular α-tocopherol and alkanoates thereof
CN2004800433093A CN1968943B (en) 2004-06-11 2004-12-03 Process for the manufacture of chroman derivatives, especially alpha-tocopherol and alkanoates thereof
KR1020067025975A KR101140519B1 (en) 2004-06-11 2004-12-03 Process for the manufacture of chroman derivatives, especially ?-tocopherol and alkanoates thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04013713 2004-06-11
EP04013713.5 2004-06-11

Publications (1)

Publication Number Publication Date
WO2005121115A1 true WO2005121115A1 (en) 2005-12-22

Family

ID=34959527

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/013771 WO2005121115A1 (en) 2004-06-11 2004-12-03 PROCESS FOR THE MANUFACTURE OF CHROMAN DERIVATIVES, ESPECIALLY α-TOCOPHEROL AND ALKANOATES THEREOF

Country Status (6)

Country Link
US (2) US20050277777A1 (en)
EP (1) EP1778661B1 (en)
JP (2) JP4999690B2 (en)
KR (1) KR101140519B1 (en)
CN (1) CN1968943B (en)
WO (1) WO2005121115A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012025559A2 (en) 2010-08-24 2012-03-01 Dsm Ip Assets B.V. Process for the manufacture of 3,7-dimethyl-1-octen-3-ol
WO2014023848A1 (en) 2012-08-10 2014-02-13 Dsm Ip Assets B.V. Protected tocopherol with reduced content of free tocopherol
WO2014023849A1 (en) 2012-08-10 2014-02-13 Dsm Ip Assets B.V. Tocopherols with increased color stability
WO2014097173A1 (en) 2012-12-18 2014-06-26 Dsm Ip Assets B.V. (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundeca-3,5,9-trien-2-one
WO2014096067A1 (en) 2012-12-18 2014-06-26 Dsm Ip Assets B.V. (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from (r)-6,10,14-trimetylpentadec-5-en-2-one
WO2014096098A1 (en) 2012-12-18 2014-06-26 Dsm Ip Assets B.V. (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10,14-trimetylpentadeca-5,9,13-trien-2-one or 6,10,14-trimetylpentadeca-5,9-dien-2-one
WO2017108339A1 (en) 2015-12-21 2017-06-29 Dsm Ip Assets B.V. Intermolecular reaction of propargyl ethers with dimethylfuran in the presence of gold(i) complexes
WO2018096152A1 (en) 2016-11-28 2018-05-31 Dsm Ip Assets B.V. Process for preparing (poly)alkylated phenols
WO2019043251A1 (en) 2017-09-04 2019-03-07 Dsm Ip Assets B.V. 6-chromanol derivatives and their synthesis

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4917435B2 (en) * 2003-12-05 2012-04-18 ディーエスエム アイピー アセッツ ビー.ブイ. Process for producing alkenylated hydroxylated aromatic compound, chroman compound, and acylated derivatives thereof
KR101150640B1 (en) * 2003-12-15 2012-05-25 디에스엠 아이피 어셋츠 비.브이. Process for the manufacture of trimethylhydroquinone dialkanoates
BR112013004546B1 (en) * 2010-08-26 2019-04-30 Dsm Ip Assets B.V. Process for the manufacture of 2,3,5-trimethylhydro-p-benzoquinone
CN105884751A (en) * 2016-05-16 2016-08-24 中国科学院兰州化学物理研究所 Alpha-tocopherol spin labeling derivatives and preparation method thereof
CN106565659B (en) * 2016-11-01 2019-06-18 万华化学集团股份有限公司 A method of preparing vitamin e acetate
JP7346148B2 (en) 2018-09-28 2023-09-19 キヤノン株式会社 liquid discharge head
CN113105496B (en) * 2021-03-19 2022-06-14 华南理工大学 Method for synthesizing o-alkenylphenol derivative through nickel-catalyzed ring opening of benzofuran

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3789086A (en) * 1971-01-11 1974-01-29 Hoffmann La Roche Method for producing chromanols
EP0100471A1 (en) * 1982-07-29 1984-02-15 BASF Corporation Alpha tocopherol process
EP0694541A1 (en) * 1994-07-27 1996-01-31 Eisai Co., Ltd. Process for the preparation of alpha-tocopherol
WO2004063182A1 (en) * 2003-01-13 2004-07-29 Dsm Ip Assets B.V. PROCESS FOR THE MANUFACTURE OF α-TOCOPHERYL ACETATE

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2411967A (en) * 1938-03-31 1946-12-03 Hoffmann La Roche Dl-tocopherols and process for the manufacture of same
US3708505A (en) * 1971-02-25 1973-01-02 Diamond Shamrock Corp Process for preparation of d,l-alpha tocopherol
DE2606830C3 (en) 1976-02-20 1981-08-27 Basf Ag, 6700 Ludwigshafen Process for the production of tocopherol
US4191692A (en) * 1976-02-20 1980-03-04 Basf Aktiengesellschaft Manufacture of tocopherol
JPS5673081A (en) 1979-11-21 1981-06-17 Eisai Co Ltd Preparation of tocopherol acetate
DE4243464A1 (en) * 1992-12-22 1994-06-23 Basf Ag Process for the preparation of alpha-tocopherol and alpha-tocopheryl acetate in liquid or supercritical carbon dioxide
JP2644460B2 (en) * 1994-07-27 1997-08-25 エーザイ株式会社 Method for producing α-tocopherol
DE19654038A1 (en) 1996-12-23 1998-06-25 Basf Ag Preparation of alpha-tocopherol or alpha-tocopheryl acetate
DE19704619A1 (en) * 1997-02-07 1998-08-13 Basf Ag Process for the preparation of tocopheryl carboxylic esters or tocotrienyl esters by acid-catalyzed reaction with carboxylic acids
CA2288851A1 (en) * 1998-11-11 2000-05-11 F. Hoffmann-La Roche Ag Process for manufacturing d,i-alpha-tocopherol
KR100452291B1 (en) * 1999-12-14 2004-10-08 에스케이 주식회사 Method for preparing DL-α-tocopherol with a high yield and purity
DE10011402A1 (en) * 2000-03-09 2001-09-13 Degussa Process for the preparation of alpha-tocopherol esters
DE10011403A1 (en) * 2000-03-09 2001-09-13 Degussa Production of alpha-tocopherol acetate useful as feed additive involves condensation of trimethylhydroquinone and isophytol in presence of a regenerable catalyst system followed by acylation of the resultant alpha-tocopherol
AU2002227934A1 (en) * 2000-11-22 2002-06-03 Basf Aktiengesellschaft Method for continuously acylating chromanol ester derivatives
JP4917435B2 (en) * 2003-12-05 2012-04-18 ディーエスエム アイピー アセッツ ビー.ブイ. Process for producing alkenylated hydroxylated aromatic compound, chroman compound, and acylated derivatives thereof
CA2563161C (en) * 2004-04-16 2017-01-24 Wayne State University Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3, 6-disubstituted pyran derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3789086A (en) * 1971-01-11 1974-01-29 Hoffmann La Roche Method for producing chromanols
EP0100471A1 (en) * 1982-07-29 1984-02-15 BASF Corporation Alpha tocopherol process
EP0694541A1 (en) * 1994-07-27 1996-01-31 Eisai Co., Ltd. Process for the preparation of alpha-tocopherol
WO2004063182A1 (en) * 2003-01-13 2004-07-29 Dsm Ip Assets B.V. PROCESS FOR THE MANUFACTURE OF α-TOCOPHERYL ACETATE

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012025559A2 (en) 2010-08-24 2012-03-01 Dsm Ip Assets B.V. Process for the manufacture of 3,7-dimethyl-1-octen-3-ol
WO2014023848A1 (en) 2012-08-10 2014-02-13 Dsm Ip Assets B.V. Protected tocopherol with reduced content of free tocopherol
WO2014023849A1 (en) 2012-08-10 2014-02-13 Dsm Ip Assets B.V. Tocopherols with increased color stability
WO2014097173A1 (en) 2012-12-18 2014-06-26 Dsm Ip Assets B.V. (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundeca-3,5,9-trien-2-one
WO2014096067A1 (en) 2012-12-18 2014-06-26 Dsm Ip Assets B.V. (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from (r)-6,10,14-trimetylpentadec-5-en-2-one
WO2014096098A1 (en) 2012-12-18 2014-06-26 Dsm Ip Assets B.V. (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10,14-trimetylpentadeca-5,9,13-trien-2-one or 6,10,14-trimetylpentadeca-5,9-dien-2-one
US9611200B2 (en) 2012-12-18 2017-04-04 Dsm Ip Assets B.V. (6R,10R)-6,10,14-trimetylpentadecan-2-one prepared from 6,10,14 trimetylpentadeca-5,9,13-trien-2-one or 6,10,14-trimetylpentadeca-5,9-dien-2-one
WO2017108339A1 (en) 2015-12-21 2017-06-29 Dsm Ip Assets B.V. Intermolecular reaction of propargyl ethers with dimethylfuran in the presence of gold(i) complexes
WO2018096152A1 (en) 2016-11-28 2018-05-31 Dsm Ip Assets B.V. Process for preparing (poly)alkylated phenols
WO2019043251A1 (en) 2017-09-04 2019-03-07 Dsm Ip Assets B.V. 6-chromanol derivatives and their synthesis

Also Published As

Publication number Publication date
JP2008501735A (en) 2008-01-24
EP1778661B1 (en) 2014-01-22
JP2011121968A (en) 2011-06-23
JP4999690B2 (en) 2012-08-15
EP1778661A1 (en) 2007-05-02
US20090176998A1 (en) 2009-07-09
KR101140519B1 (en) 2012-04-30
CN1968943B (en) 2011-08-10
CN1968943A (en) 2007-05-23
KR20070032679A (en) 2007-03-22
US20050277777A1 (en) 2005-12-15
US8431727B2 (en) 2013-04-30

Similar Documents

Publication Publication Date Title
US8431727B2 (en) Process for the manufacture of chroman derivatives, especially α-tocopherol and alka-noates thereof
JP2011178801A (en) Process for producing ester
US20070112206A1 (en) Manufacture of tocopheryl acetate
US20060052618A1 (en) Process for the manufacture of alpha-tocopheryl acetate
EP0949255B1 (en) Process for manufacturing d, l-alpha-tocopherol in a carbonate solvent and in the presence of a sulphur-containing acid catalyst
US7105686B2 (en) Manufacture of tocol, tocol derivatives and tocopherols
EP1622887B1 (en) Process for the manufacture of tocyl and tocopheryl acylates
EP1641772B1 (en) Manufacture of tocopherols using a bismuth catalyst
US7153984B2 (en) Manufacture of α-tocopherol
TWI378924B (en) Process for the manufacture of chroman derivatives,especially α-tocopherol and alkanoates thereof
WO2003070718A1 (en) MANUFACTURE OF (ALL-RAC)-α-TOCOPHEROL

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10584174

Country of ref document: US

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2004803493

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1020067025975

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 200480043309.3

Country of ref document: CN

Ref document number: 2007526211

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 7923/DELNP/2006

Country of ref document: IN

WWP Wipo information: published in national office

Ref document number: 1020067025975

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2004803493

Country of ref document: EP